BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV, Timmerman RD, Martel MK, Jackson A.   Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S70-6.. [PMID: 20171521 DOI: 10.1016/j.ijrobp.2009.06.091] [Cited by in Crossref: 618] [Cited by in F6Publishing: 541] [Article Influence: 51.5] [Reference Citation Analysis]
Number Citing Articles
1 Miyazaki M, Ohira S, Ueda Y, Isono M, Fujiwara M, Tanooka M, Okada W, Nakahara R, Sueoka M, Suzuki H, Teshima T, Yamakado K. Oesophageal Cancer: Conformal Radiotherapy vs. Hybrid-VMAT Technique With Two Different Treatment Planning Systems. In Vivo 2020;34:331-7. [PMID: 31882496 DOI: 10.21873/invivo.117778] [Reference Citation Analysis]
2 Patton TJ, Gerard SE, Shao W, Christensen GE, Reinhardt JM, Bayouth JE. Quantifying ventilation change due to radiation therapy using 4DCT Jacobian calculations. Med Phys 2018;45:4483-92. [PMID: 30047588 DOI: 10.1002/mp.13105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
3 Mueller M, Poulsen P, Hansen R, Verbakel W, Berbeco R, Ferguson D, Mori S, Ren L, Roeske JC, Wang L, Zhang P, Keall P. The markerless lung target tracking AAPM Grand Challenge (MATCH) results. Med Phys 2021. [PMID: 34913495 DOI: 10.1002/mp.15418] [Reference Citation Analysis]
4 Han C, Schiffner DC, Schultheiss TE, Chen YJ, Liu A, Wong JY. Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer. Radiother Oncol 2012;102:309-14. [PMID: 21872956 DOI: 10.1016/j.radonc.2011.07.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zanette B, Stirrat E, Jelveh S, Hope A, Santyr G. Physiological gas exchange mapping of hyperpolarized 129 Xe using spiral-IDEAL and MOXE in a model of regional radiation-induced lung injury. Med Phys 2018;45:803-16. [DOI: 10.1002/mp.12730] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
6 Kumar L, Kishore V, Bhushan M, Dewan A, Yadav G, Raman K, Kumar G, Ahmad I, Chufal KS, Gairola M. Impact of acuros XB algorithm in deep-inspiration breath-hold (DIBH) respiratory techniques used for the treatment of left breast cancer. Rep Pract Oncol Radiother 2020;25:507-14. [PMID: 32494224 DOI: 10.1016/j.rpor.2020.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Brodin NP, Munck Af Rosenschöld P, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, Lannering B, Björk-Eriksson T. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 2011;50:806-16. [PMID: 21767178 DOI: 10.3109/0284186X.2011.582514] [Cited by in Crossref: 104] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
8 Voshart DC, Wiedemann J, van Luijk P, Barazzuol L. Regional Responses in Radiation-Induced Normal Tissue Damage. Cancers (Basel) 2021;13:367. [PMID: 33498403 DOI: 10.3390/cancers13030367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Cole AJ, O'Hare JM, McMahon SJ, McGarry CK, Butterworth KT, McAleese J, Jain S, Hounsell AR, Prise KM, Hanna GG, O'Sullivan JM. Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy. Clin Oncol (R Coll Radiol) 2014;26:142-50. [PMID: 24332210 DOI: 10.1016/j.clon.2013.11.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
10 Rajan Radha R, Chandrasekharan G. Pulmonary injury associated with radiation therapy - Assessment, complications and therapeutic targets. Biomed Pharmacother 2017;89:1092-104. [PMID: 28298070 DOI: 10.1016/j.biopha.2017.02.106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
11 Liang X, Penagaricano J, Zheng D, Morrill S, Zhang X, Corry P, Griffin RJ, Han EY, Hardee M, Ratanatharathom V. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans. Radiat Oncol 2016;11:10. [PMID: 26800883 DOI: 10.1186/s13014-015-0578-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
12 Vinogradskiy Y, Diot Q, Kavanagh B, Schefter T, Gaspar L, Miften M. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy: Evaluating fibrotic lung changes after SBRT. Med Phys 2013;40:081712. [DOI: 10.1118/1.4813916] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
13 Clement C, Stewart F, Akleyev A, Hauer-jensen M, Hendry J, Kleiman N, Macvittie T, Aleman B, Edgar A, Mabuchi K, Muirhead C, Shore R, Wallace W. ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context. Ann ICRP 2012;41:1-322. [DOI: 10.1016/j.icrp.2012.02.001] [Cited by in Crossref: 571] [Cited by in F6Publishing: 415] [Article Influence: 57.1] [Reference Citation Analysis]
14 Meynard C, Mansuet-Lupo A, Giraud N, Boulle G, Imbault P, Guénégou-Arnoux A, Bobbio A, Durdux C, Damotte D, Giraud P. Size and Predictive Factors of Microscopic Tumor Extension in Locally Advanced Non-Small Cell Lung Cancer. Pract Radiat Oncol 2021:S1879-8500(21)00156-9. [PMID: 34126295 DOI: 10.1016/j.prro.2021.05.006] [Reference Citation Analysis]
15 Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 2012;39:1386-409. [PMID: 22380372 DOI: 10.1118/1.3685447] [Cited by in Crossref: 125] [Cited by in F6Publishing: 100] [Article Influence: 13.9] [Reference Citation Analysis]
16 Holyoake DLP, Partridge M, Hawkins MA. Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy. Radiother Oncol 2019;138:38-44. [PMID: 31136961 DOI: 10.1016/j.radonc.2019.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
17 Kipritidis J, Siva S, Hofman MS, Callahan J, Hicks RJ, Keall PJ. Validating and improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using 68 Ga-labeled nanoparticles: Validating CT ventilation imaging using PET-Galligas. Med Phys 2014;41:011910. [DOI: 10.1118/1.4856055] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
18 Pang H, Sun X, Yang B, Wu J. A quality control method for intensity-modulated radiation therapy planning based on generalized equivalent uniform dose. J Appl Clin Med Phys 2018;19:276-82. [PMID: 29696777 DOI: 10.1002/acm2.12331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Hirose TA, Arimura H, Ninomiya K, Yoshitake T, Fukunaga JI, Shioyama Y. Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy. Sci Rep 2020;10:20424. [PMID: 33235324 DOI: 10.1038/s41598-020-77552-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Vinogradskiy Y, Tucker SL, Liao Z, Martel MK. Balancing radiation pneumonitis versus locoregional tumor control in non-small-cell lung cancer. J Thorac Oncol 2013;8:e47-8. [PMID: 23584304 DOI: 10.1097/JTO.0b013e31828cb6fa] [Reference Citation Analysis]
21 Dhami G, Zeng J, Vesselle HJ, Kinahan PE, Miyaoka RS, Patel SA, Rengan R, Bowen SR. Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry. Strahlenther Onkol 2017;193:410-8. [PMID: 28255667 DOI: 10.1007/s00066-017-1114-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
22 Kida S, Bal M, Kabus S, Negahdar M, Shan X, Loo BW, Keall PJ, Yamamoto T. CT ventilation functional image-based IMRT treatment plans are comparable to SPECT ventilation functional image-based plans. Radiotherapy and Oncology 2016;118:521-7. [DOI: 10.1016/j.radonc.2016.02.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
23 Stahel R, Thatcher N, Früh M, Le Péchoux C, Postmus PE, Sorensen JB, Felip E; Panel members. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. Ann Oncol 2011;22:1973-80. [PMID: 21727198 DOI: 10.1093/annonc/mdr313] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
24 Kup PG, Nieder C, Geinitz H, Henkenberens C, Besserer A, Oechsner M, Schill S, Mücke R, Scherer V, Combs SE, Adamietz IA, Fakhrian K. The prognostic value of irradiated lung volumes on the prediction of intra-/ post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study. J Cancer 2015;6:254-60. [PMID: 25663943 DOI: 10.7150/jca.10796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Miao J, Yan H, Tian Y, Ma P, Liu Z, Li M, Ren W, Chen J, Zhang Y, Dai J. Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer. J Appl Clin Med Phys 2017;18:169-76. [PMID: 29024297 DOI: 10.1002/acm2.12200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
26 Duma MN, Berndt J, Rondak IC, Devecka M, Wilkens JJ, Geinitz H, Combs SE, Oechsner M. Implications of free breathing motion assessed by 4D-computed tomography on the delivered dose in radiotherapy for esophageal cancer. Med Dosim 2015;40:378-82. [PMID: 26419857 DOI: 10.1016/j.meddos.2015.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Gordon JJ, Snyder K, Zhong H, Barton K, Sun Z, Chetty IJ, Matuszak M, Ten Haken RK. Extracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance. Phys Med Biol 2015;60:6719-32. [PMID: 26295744 DOI: 10.1088/0031-9155/60/17/6719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Li R, Pu X, Chang JY, Ye Y, Komaki R, Minna JD, Roth JA, Han B, Wu X. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer. PLoS One 2016;11:e0150467. [PMID: 26991123 DOI: 10.1371/journal.pone.0150467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Pemberton M, Brady C, Taylor B, Tyrrell D, Sim L, Zawlodzka-Bednarz S, Biggs J, Peters M, Baines J, Hargrave C. Modification of a modulated arc total body irradiation technique: Implementation and first clinical experience for paediatric patients. J Med Radiat Sci 2018;65:291-9. [PMID: 30230247 DOI: 10.1002/jmrs.305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Wedenberg M. Assessing the uncertainty in QUANTEC's dose-response relation of lung and spinal cord with a bootstrap analysis. Int J Radiat Oncol Biol Phys 2013;87:795-801. [PMID: 23953634 DOI: 10.1016/j.ijrobp.2013.06.2040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wang K, Tepper JE. Radiation therapy-associated toxicity: Etiology, management, and prevention. CA Cancer J Clin 2021. [PMID: 34255347 DOI: 10.3322/caac.21689] [Reference Citation Analysis]
32 Lan F, Jeudy J, Senan S, van Sornsen de Koste JR, D'Souza W, Tseng HH, Zhou J, Zhang H. Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications? Med Phys 2016;43:5072. [PMID: 27587037 DOI: 10.1118/1.4960367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
33 Liu X, Shao C, Fu J. Promising Biomarkers of Radiation-Induced Lung Injury: A Review. Biomedicines 2021;9:1181. [PMID: 34572367 DOI: 10.3390/biomedicines9091181] [Reference Citation Analysis]
34 Andruska N, Mahapatra L, Hebbard C, Patel P, Paul V. Severe pneumonitis refractory to steroids following anti-PD-1 immunotherapy. BMJ Case Rep. 2018;2018. [PMID: 30301729 DOI: 10.1136/bcr-2018-225937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
35 Harder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Pract Radiat Oncol 2015;5:e643-9. [PMID: 26412341 DOI: 10.1016/j.prro.2015.07.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
36 Guo L, Ding G, Xu W, Lu Y, Ge H, Jiang Y, Chen X, Li Y. Prognostic biological factors of radiation pneumonitis after stereotactic body radiation therapy combined with pulmonary perfusion imaging. Exp Ther Med 2019;17:244-50. [PMID: 30651789 DOI: 10.3892/etm.2018.6936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Quirk S, Grendarova P, Craighead P, Phan T, Lesiuk M, Pinilla J, Liu H, Wilson J, Bignell K, Austin T, Olivotto IA, Roumeliotis M. Results of the ACCEL trial: Dosimetry in accelerated partial breast irradiation. Radiotherapy and Oncology 2020;147:50-5. [DOI: 10.1016/j.radonc.2020.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Scotti V, Marrazzo L, Saieva C, Agresti B, Meattini I, Desideri I, Cecchini S, Bertocci S, Franzese C, De Luca Cardillo C, Zei G, Loi M, Greto D, Mangoni M, Bonomo P, Livi L, Biti GP. Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. Radiol med 2014;119:13-9. [DOI: 10.1007/s11547-013-0307-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
39 Small W Jr, James JL, Moore TD, Fintel DJ, Lutz ST, Movsas B, Suntharalingam M, Garces YI, Ivker R, Moulder J, Pugh S, Berk LB. Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123. Am J Clin Oncol 2018;41:396-401. [PMID: 27100959 DOI: 10.1097/COC.0000000000000289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
40 De Ruysscher D, Chang JY. Clinical Controversies: Proton Therapy for Thoracic Tumors. Seminars in Radiation Oncology 2013;23:115-9. [DOI: 10.1016/j.semradonc.2012.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
41 Indelicato DJ, Mailhot Vega RB, Viviers E, Morris CG, Bradfield SM, Gibbs CP, Bradley JA. Modern Therapy for Chest Wall Ewing Sarcoma: An Update of the XXX Experience. International Journal of Radiation Oncology*Biology*Physics 2022. [DOI: 10.1016/j.ijrobp.2022.02.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Mah D, Yorke E, Zemanaj E, Han Z, Liu H, George J, Lambiase J, Czmielewski C, Lovelock DM, Rimner A, Shepherd AF. A Planning Comparison of IMRT vs. Pencil Beam Scanning for Deep Inspiration Breath Hold Lung Cancers. Med Dosim 2021:S0958-3947(21)00069-8. [PMID: 34426041 DOI: 10.1016/j.meddos.2021.07.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol 2014;53:605-12. [PMID: 23957623 DOI: 10.3109/0284186X.2013.820341] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
44 Dupic G, Biau J, Molnar I, Chassin V, Dedieu V, Lapeyre M, Bellière-Calandry A. Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT). Front Oncol 2020;10:1577. [PMID: 32850462 DOI: 10.3389/fonc.2020.01577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Baker R, Han G, Sarangkasiri S, DeMarco M, Turke C, Stevens CW, Dilling TJ. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys. 2013;85:190-195. [PMID: 22929858 DOI: 10.1016/j.ijrobp.2012.03.041] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 9.6] [Reference Citation Analysis]
46 Billiet C, Peeters S, De Ruysscher D. Focus on treatment complications and optimal management: radiation oncology. Transl Lung Cancer Res 2014;3:187-91. [PMID: 25806299 DOI: 10.3978/j.issn.2218-6751.2014.06.08] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Basaula D, Quinn A, Walker A, Batumalai V, Kumar S, Delaney GP, Holloway L. Risks and benefits of reducing target volume margins in breast tangent radiotherapy. Australas Phys Eng Sci Med 2017;40:305-15. [PMID: 28243923 DOI: 10.1007/s13246-017-0529-3] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
48 Lambin P, Zindler J, Vanneste BG, De Voorde LV, Eekers D, Compter I, Panth KM, Peerlings J, Larue RT, Deist TM, Jochems A, Lustberg T, van Soest J, de Jong EE, Even AJ, Reymen B, Rekers N, van Gisbergen M, Roelofs E, Carvalho S, Leijenaar RT, Zegers CM, Jacobs M, van Timmeren J, Brouwers P, Lal JA, Dubois L, Yaromina A, Van Limbergen EJ, Berbee M, van Elmpt W, Oberije C, Ramaekers B, Dekker A, Boersma LJ, Hoebers F, Smits KM, Berlanga AJ, Walsh S. Decision support systems for personalized and participative radiation oncology. Adv Drug Deliv Rev 2017;109:131-53. [PMID: 26774327 DOI: 10.1016/j.addr.2016.01.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 14.0] [Reference Citation Analysis]
49 McCall R, MacLennan G, Taylor M, Lenards N, Nelms BE, Koshy M, Lemons J, Hunzeker A. Anatomical contouring variability in thoracic organs at risk. Med Dosim 2016;41:344-50. [PMID: 27839589 DOI: 10.1016/j.meddos.2016.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
50 Smits KM, Melotte V, Niessen HE, Dubois L, Oberije C, Troost EG, Starmans MH, Boutros PC, Vooijs M, van Engeland M, Lambin P. Epigenetics in radiotherapy: Where are we heading? Radiotherapy and Oncology 2014;111:168-77. [DOI: 10.1016/j.radonc.2014.05.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
51 Yoon J, Heins D, Zhao X, Sanders M, Zhang R. Measurement and modeling of out-of-field doses from various advanced post-mastectomy radiotherapy techniques. Phys Med Biol 2017;62:9039-53. [PMID: 29048329 DOI: 10.1088/1361-6560/aa94b5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Yafeng L, Jing W, Jiawei Z, Yingru X, Xin Z, Danting L, Jun X, Chang T, Min M, Xuansheng D, Dong H. Construction and Verification of a Radiation Pneumonia Prediction Model Based on Multiple Parameters. Cancer Control 2021;28:10732748211026671. [PMID: 34263661 DOI: 10.1177/10732748211026671] [Reference Citation Analysis]
53 Yu HH, Chengchuan Ko E, Chang CL, Yuan KS, Wu ATH, Shan YS, Wu SY. Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues. Mar Drugs 2018;16:E392. [PMID: 30347679 DOI: 10.3390/md16100392] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
54 Dicuonzo S, Patti F, Luraschi R, Frassoni S, Rojas DP, Zaffaroni M, Morra A, Gerardi MA, Zerella MA, Emiro F, Cattani F, Bagnardi V, Fodor CI, Veronesi P, Galimberti VE, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction. Phys Med 2021;90:66-72. [PMID: 34563833 DOI: 10.1016/j.ejmp.2021.09.007] [Reference Citation Analysis]
55 Giaj-Levra N, Ricchetti F, Alongi F. What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review. Cancer Invest 2016;34:80-93. [PMID: 26810755 DOI: 10.3109/07357907.2015.1114121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
56 Scheenstra AE, Rossi MM, Belderbos JS, Damen EM, Lebesque JV, Sonke J. Local dose–effect relations for lung perfusion post stereotactic body radiotherapy. Radiotherapy and Oncology 2013;107:398-402. [DOI: 10.1016/j.radonc.2013.04.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
57 Matuszak MM, Matrosic C, Jarema D, McShan DL, Stenmark MH, Owen D, Jolly S, Kong FS, Ten Haken RK. Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imaging. Adv Radiat Oncol 2016;1:281-9. [PMID: 28740898 DOI: 10.1016/j.adro.2016.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Collie D, Murchison JT, Wright SH, McLean A, Howard L, Del-Pozo J, Smith S, McLachlan G, Lawrence J, Kay E, Schwarz T, Parys M. Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model. Sci Rep 2018;8:13316. [PMID: 30190567 DOI: 10.1038/s41598-018-31559-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Eslick EM, Stevens MJ, Bailey DL. SPECT V/Q in Lung Cancer Radiotherapy Planning. Semin Nucl Med 2019;49:31-6. [PMID: 30545514 DOI: 10.1053/j.semnuclmed.2018.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
60 Bourbonne V, Delafoy A, Lucia F, Quéré G, Pradier O, Schick U. Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study. Transl Lung Cancer Res 2021;10:156-66. [PMID: 33569301 DOI: 10.21037/tlcr-20-406] [Reference Citation Analysis]
61 Py JF, Salleron J, Courrech F, Beckendorf V, Croisé-Laurent V, Peiffert D, Vogin G, Dietmann AS. Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancer. Cancer Radiother 2021;25:350-7. [PMID: 33618909 DOI: 10.1016/j.canrad.2021.01.004] [Reference Citation Analysis]
62 Caudrelier J, Truong P. Role of hypofractionated radiotherapy in breast locoregional radiation. Cancer/Radiothérapie 2015;19:241-7. [DOI: 10.1016/j.canrad.2015.02.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
63 Mounessi FS, Eckardt J, Holstein A, Ewig S, Könemann S. Image-based lung functional radiotherapy planning for non-small cell lung cancer. Strahlenther Onkol 2020;196:151-8. [DOI: 10.1007/s00066-019-01518-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Josipovic M, Persson GF, Håkansson K, Damkjær SM, Bangsgaard JP, Westman G, Riisgaard S, Specht L, Aznar MC. Deep inspiration breath hold radiotherapy for locally advanced lung cancer: comparison of different treatment techniques on target coverage, lung dose and treatment delivery time. Acta Oncol 2013;52:1582-6. [PMID: 24047341 DOI: 10.3109/0284186X.2013.813644] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
65 Parekh AD, Indelicato DJ, Hoppe BS, Vega RBM, Rotondo RL, Bradley JA. Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis? Pediatr Blood Cancer 2021;:e29287. [PMID: 34398486 DOI: 10.1002/pbc.29287] [Reference Citation Analysis]
66 Forschner A, Zips D, Schraml C, Röcken M, Iordanou E, Leiter U, Weide B, Garbe C, Meier F. Radiation recall dermatitis and radiation pneumonitis during treatment with vemurafenib. Melanoma Res 2014;24:512-6. [PMID: 24743051 DOI: 10.1097/CMR.0000000000000078] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
67 Flaum N, Lorigan P, Whitfield GA, Hawkins RE, Pinkham MB. Integrating radiation therapy with emerging systemic therapies: Lessons from a patient with cerebral radionecrosis, spinal cord myelopathy, and radiation pneumonitis. Pract Radiat Oncol 2016;6:110-3. [PMID: 26723549 DOI: 10.1016/j.prro.2015.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Takamiya M, Nakamura M, Akimoto M, Ueki N, Yamada M, Tanabe H, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M, Itoh A. Multivariate analysis for the estimation of target localization errors in fiducial marker-based radiotherapy. Med Phys 2016;43:1907. [PMID: 27036586 DOI: 10.1118/1.4944594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
69 Chen H, Wang H, Gu H, Shao Y, Cai X, Fu X, Xu Z. Study for reducing lung dose of upper thoracic esophageal cancer radiotherapy by auto-planning: volumetric-modulated arc therapy vs intensity-modulated radiation therapy. Med Dosim 2018;43:243-50. [PMID: 29110926 DOI: 10.1016/j.meddos.2017.09.001] [Cited by in Crossref: 10] [Article Influence: 2.0] [Reference Citation Analysis]
70 Mulryan K, Leech M, Forde E. Effect of stereotactic dosimetric end points on overall survival for Stage I non-small cell lung cancer: a critical review. Med Dosim 2015;40:340-6. [PMID: 26031415 DOI: 10.1016/j.meddos.2015.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
71 Yahya N, Chua X, Manan HA, Ismail F. Inclusion of dosimetric data as covariates in toxicity-related radiogenomic studies: A systematic review. Strahlenther Onkol 2018;194:780-6. [DOI: 10.1007/s00066-018-1303-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
72 Bourbonne V, Da-Ano R, Jaouen V, Lucia F, Dissaux G, Bert J, Pradier O, Visvikis D, Hatt M, Schick U. Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer. Radiother Oncol 2021;155:144-50. [PMID: 33161012 DOI: 10.1016/j.radonc.2020.10.040] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 De Bari B, Deantonio L, Bourhis J, Prior JO, Ozsahin M. Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature. Crit Rev Oncol Hematol 2016;102:111-7. [PMID: 27132077 DOI: 10.1016/j.critrevonc.2016.04.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
74 Atkins KM, Chaunzwa TL, Lamba N, Bitterman DS, Rawal B, Bredfeldt J, Williams CL, Kozono DE, Baldini EH, Nohria A, Hoffmann U, Aerts HJWL, Mak RH. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer. JAMA Oncol 2021;7:206-19. [PMID: 33331883 DOI: 10.1001/jamaoncol.2020.6332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
75 Su Z, Indelicato DJ, Mailhot RB, Bradley JA. Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture. J Appl Clin Med Phys 2020;21:100-7. [PMID: 32268008 DOI: 10.1002/acm2.12870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
76 Scherman J, Appelt AL, Yu J, Persson GF, Nygård L, Langendijk JA, Bentzen SM, Vogelius IR. Incorporating NTCP into Randomized Trials of Proton Versus Photon Therapy. Int J Part Ther 2019;5:24-32. [PMID: 31788505 DOI: 10.14338/IJPT-18-00038.1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Yamamoto T, Kabus S, Bal M, Bzdusek K, Keall PJ, Wright C, Benedict SH, Daly ME. Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer. Int J Radiat Oncol Biol Phys 2018;102:1366-73. [PMID: 29891207 DOI: 10.1016/j.ijrobp.2018.04.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
78 Palmer JD, Zaorsky NG, Witek M, Lu B. Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer. J Thorac Dis 2014;6:387-98. [PMID: 24688783 DOI: 10.3978/j.issn.2072-1439.2013.12.04] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
79 Mizuno N, Yamauchi R, Kawamori J, Itazawa T, Shimbo M, Nishimura K, Yamano T, Hatanaka S, Hariu M, Takahashi T. Evaluation of a new commercial automated planning software for tangential breast intensity-modulated radiation therapy. Radiol Phys Technol 2019;12:249-59. [PMID: 31115835 DOI: 10.1007/s12194-019-00515-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Jing S, Guo H, Qi Y, Yang G, Huang Y. A portable fast neutron irradiation system for tumor therapy. Appl Radiat Isot 2020;160:109138. [PMID: 32351230 DOI: 10.1016/j.apradiso.2020.109138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Xu C, Guo L, Liao Z, Wang Y, Liu X, Zhao S, Wang J, Yuan Z, Wang P, Lin SH. Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy. Clin Transl Radiat Oncol 2019;17:17-23. [PMID: 31080898 DOI: 10.1016/j.ctro.2019.04.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
82 Rastogi K, Sharma S, Gupta S, Agarwal N, Bhaskar S, Jain S. Dosimetric comparison of IMRT versus 3DCRT for post-mastectomy chest wall irradiation. Radiat Oncol J 2018;36:71-8. [PMID: 29621872 DOI: 10.3857/roj.2017.00381] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
83 Kutara K, Mochizuki Y, Ohnishi A, Mitsui I, Kanda T, Sugiyama A, Maeta N, Kobayashi K, Shimizu Y, Okamura Y, Asanuma T. The Outcome and CT Findings of Low-Dose Intensity Modulated Radiation Therapy with SQAP in a Cat with Thymoma. Vet Sci 2020;7:E203. [PMID: 33327647 DOI: 10.3390/vetsci7040203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Shiau AC, Hsieh CH, Tien HJ, Yeh HP, Lin CT, Shueng PW, Wu LJ. Left-sided whole breast irradiation with hybrid-IMRT and helical tomotherapy dosimetric comparison. Biomed Res Int 2014;2014:741326. [PMID: 25170514 DOI: 10.1155/2014/741326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
85 Merrell KW, Davis BJ, Goulet CC, Furutani KM, Mynderse LA, Harmsen WS, Wilson TM, McLaren RH, Deufel CL, Birckhead BJ, Funk RK, McMenomy BP, Stish BJ, Choo CR. Reducing seed migration to near zero with stranded-seed implants: Comparison of seed migration rates to the chest in 1000 permanent prostate brachytherapy patients undergoing implants with loose or stranded seeds. Brachytherapy 2019;18:306-12. [PMID: 30853392 DOI: 10.1016/j.brachy.2019.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Bahig H, Campeau M, Lapointe A, Bedwani S, Roberge D, de Guise J, Blais D, Vu T, Lambert L, Chartrand-lefebvre C, Lord M, Filion E. Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning. International Journal of Radiation Oncology*Biology*Physics 2017;99:334-43. [DOI: 10.1016/j.ijrobp.2017.05.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
87 Nahum AE. The radiobiology of hypofractionation. Clin Oncol (R Coll Radiol) 2015;27:260-9. [PMID: 25797579 DOI: 10.1016/j.clon.2015.02.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
88 Schlampp I, Rieber J, Adeberg S, Bozorgmehr F, Heußel CP, Steins M, Kappes J, Hoffmann H, Welzel T, Debus J, Rieken S. Re-irradiation in locally recurrent lung cancer patients. Strahlenther Onkol 2019;195:725-33. [PMID: 30937509 DOI: 10.1007/s00066-019-01457-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
89 Tsukita Y, Yamamoto T, Mayahara H, Hata A, Takeda Y, Nakayama H, Tanaka S, Uchida J, Usui K, Toyoda T, Tamiya M, Morimoto M, Oya Y, Kodaira T, Miyauchi E, Jingu K, Sugiura H. Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study. Radiother Oncol 2021;160:266-72. [PMID: 34023330 DOI: 10.1016/j.radonc.2021.05.016] [Reference Citation Analysis]
90 Møller DS, Khalil AA, Knap MM, Muren LP, Hoffmann L. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients. Acta Oncol 2011;50:883-8. [PMID: 21767188 DOI: 10.3109/0284186X.2011.581694] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
91 Kelsey CR, Rosenstein BS, Marks LB. Predicting toxicity from radiation therapy--it's genetic, right? Cancer 2012;118:3450-4. [PMID: 22144075 DOI: 10.1002/cncr.26670] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
92 Salem A, Mistry H, Backen A, Hodgson C, Koh P, Dean E, Priest L, Haslett K, Trigonis I, Jackson A, Asselin MC, Dive C, Renehan A, Faivre-Finn C, Blackhall F. Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging. Clin Lung Cancer 2018;19:239-248.e7. [PMID: 29398577 DOI: 10.1016/j.cllc.2017.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
93 Troost EGC, Wink KCJ, Roelofs E, Simone CB 2nd, Makocki S, Löck S, van Kollenburg P, Dechambre D, Minken AWH, van der Stoep J, Avery S, Jansen N, Solberg T, Bussink J, de Ruysscher D. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study. Br J Radiol 2020;93:20190879. [PMID: 31804145 DOI: 10.1259/bjr.20190879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
94 Le Péchoux C. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist 2011;16:672-81. [PMID: 21378080 DOI: 10.1634/theoncologist.2010-0150] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 7.8] [Reference Citation Analysis]
95 Bonner Millar LP, Stripp D, Cooper JD, Both S, James P, Rengan R. Definitive Radiotherapy for Unresected Adenoid Cystic Carcinoma of the Trachea. Chest 2012;141:1323-6. [DOI: 10.1378/chest.11-0925] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
96 Agrawal S, Kumar S, Lawrence A, Das MK, Kumar S. Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy. South Asian J Cancer 2014;3:13-5. [PMID: 24665439 DOI: 10.4103/2278-330X.126503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
97 Chandy E, Szmul A, Stavropoulou A, Jacob J, Veiga C, Landau D, Wilson J, Gulliford S, Fenwick JD, Hawkins MA, Hiley C, McClelland JR. Quantitative Analysis of Radiation-Associated Parenchymal Lung Change. Cancers (Basel) 2022;14:946. [PMID: 35205693 DOI: 10.3390/cancers14040946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
98 Choi MG, Lee HY, Song SY, Kim SS, Lee SH, Kim W, Choi CM, Lee SW. The Effects of Simultaneous Pulmonary Rehabilitation during Thoracic Radiotherapy in the Treatment of Malignant Diseases. Tuberc Respir Dis (Seoul) 2021;84:148-58. [PMID: 33587837 DOI: 10.4046/trd.2020.0135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock DN, Blackstock AW, Hinson WH, Munley MT, Petty WJ, Urbanic JJ. Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)? Cureus 2016;8:e466. [PMID: 26929893 DOI: 10.7759/cureus.466] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
100 Zhang Y, Wang H, Huang X, Zhang Q, Ren R, Sun R, Zheng Z, Dong S, Zheng A. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma. Med Dosim 2019;44:167-72. [PMID: 29950277 DOI: 10.1016/j.meddos.2018.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Rahi MS, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S, Subramaniyam R, Jeyashanmugaraja GP, Gunasekaran K. Radiation-Induced Lung Injury-Current Perspectives and Management. Clin Pract 2021;11:410-29. [PMID: 34287252 DOI: 10.3390/clinpract11030056] [Reference Citation Analysis]
102 Defraene G, van Elmpt W, De Ruysscher D. Regional lung avoidance by CT numbers to reduce radiation-induced lung damage risk in non-small-cell lung cancer: a simulation study. Acta Oncol 2020;59:201-7. [PMID: 31549562 DOI: 10.1080/0284186X.2019.1669814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Xu F, Han JC, Zhang YJ, Zhang YJ, Liu XC, Qi GB, Liu D, Chen YZ, Zhao YX, Bai L. Associations of LIG4 and HSPB1 genetic polymorphisms with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy. Biomed Res Int 2015;2015:860373. [PMID: 25811031 DOI: 10.1155/2015/860373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
104 Dabjan MB, Buck CM, Jackson IL, Vujaskovic Z, Marples B, Down JD. A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain. Lab Invest 2016;96:936-49. [DOI: 10.1038/labinvest.2016.76] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
105 Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. Correlation of Clinical and Dosimetric Factors With Adverse Pulmonary Outcomes in Children After Lung Irradiation. International Journal of Radiation Oncology*Biology*Physics 2013;86:942-8. [DOI: 10.1016/j.ijrobp.2013.04.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
106 Weiss E, Fatyga M, Wu Y, Dogan N, Balik S, Sleeman W 4th, Hugo G. Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost. Int J Radiat Oncol Biol Phys 2013;86:414-9. [PMID: 23523321 DOI: 10.1016/j.ijrobp.2012.12.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
107 Vinogradskiy Y, Tucker SL, Bluett JB, Wages CA, Liao Z, Martel MK. Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates. J Thorac Oncol 2012;7:1676-82. [PMID: 23059778 DOI: 10.1097/JTO.0b013e318269410a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
108 Bainbridge HE, Menten MJ, Fast MF, Nill S, Oelfke U, McDonald F. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy. Radiother Oncol 2017;125:280-5. [PMID: 28987747 DOI: 10.1016/j.radonc.2017.09.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
109 Xie Y, Bourgeois D, Guo B, Zhang R. Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery. Med Dosim 2020;45:e9-e16. [PMID: 32646715 DOI: 10.1016/j.meddos.2020.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
110 Lutz CM, Møller DS, Hoffmann L, Knap MM, Alber M. Reliability of dose volume constraint inference from clinical data. Phys Med Biol 2017;62:3250-62. [PMID: 28350545 DOI: 10.1088/1361-6560/aa63d4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 Yakar M, Etiz D, Metintas M, Ak G, Celik O. Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study. Technol Cancer Res Treat 2021;20:15330338211016373. [PMID: 33969761 DOI: 10.1177/15330338211016373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 van Elmpt W, De Ruysscher D, van der Salm A, Lakeman A, van der Stoep J, Emans D, Damen E, Öllers M, Sonke J, Belderbos J. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. Radiotherapy and Oncology 2012;104:67-71. [DOI: 10.1016/j.radonc.2012.03.005] [Cited by in Crossref: 163] [Cited by in F6Publishing: 144] [Article Influence: 16.3] [Reference Citation Analysis]
113 Abuodeh Y, Naghavi AO, Echevarria M, DeMarco M, Tonner B, Feygelman V, Stevens CW, Perez BA, Dilling TJ. Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis. Clin Lung Cancer 2018;19:e123-30. [PMID: 29107487 DOI: 10.1016/j.cllc.2017.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
114 Jain V, Niezink AGH, Frick M, Doucette A, Mendes A, Simone CB 2nd, Langendijk JA, Wijsman R, Feigenberg SJ, Levin W, Cengel KA, van der Schaaf A, Berman AT. Updating Photon-Based Normal Tissue Complication Probability Models for Pneumonitis in Patients With Lung Cancer Treated With Proton Beam Therapy. Pract Radiat Oncol 2020;10:e330-8. [PMID: 32416270 DOI: 10.1016/j.prro.2020.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
115 Prado C, Kazi A, Bennett A, MacVittie T, Prado K. Mean Organ Doses Resulting From Non-Human Primate Whole Thorax Lung Irradiation Prescribed to Mid-Line Tissue. Health Phys 2015;109:367-73. [PMID: 26425898 DOI: 10.1097/HP.0000000000000336] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
116 Herbert C, Kwa W, Nakano S, James K, Moiseenko V, Wu J, Schellenberg D, Liu M. Stereotactic Body Radiotherapy: Volumetric Modulated Arc Therapy versus 3D Non-Coplanar Conformal Radiotherapy for the Treatment of Early Stage Lung Cancer. Technol Cancer Res Treat 2013;12:511-6. [DOI: 10.7785/tcrt.2012.500338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
117 Farr KP, Khalil AA, Knap MM, Møller DS, Grau C. Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients. Radiother Oncol 2013;107:382-8. [PMID: 23726117 DOI: 10.1016/j.radonc.2013.04.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
118 Smith SK, Estoesta RP, Kader JA, Martin D, Claridge-mackonis ER, Toohey JM, Carroll SL. Hybrid intensity-modulated radiation therapy (IMRT) simultaneous integrated boost (SIB) technique versus three-dimensional (3D) conformal radiotherapy with SIB for breast radiotherapy: a planning comparison. J Radiother Pract 2016;15:131-42. [DOI: 10.1017/s146039691600008x] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
119 Kirkby C. A model of infection and immune response to low dose radiation. Int J Radiat Biol 2022;:1-14. [PMID: 34995150 DOI: 10.1080/09553002.2022.2020361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Lee S, Ybarra N, Jeyaseelan K, Faria S, Kopek N, Brisebois P, Bradley JD, Robinson C, Seuntjens J, El Naqa I. Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk. Med Phys 2015;42:2421-30. [PMID: 25979036 DOI: 10.1118/1.4915284] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
121 Kara FG, Haydaroğlu A, Eren H, Kitapçıoğlu G. Comparison of Different Techniques in Breast Cancer Radiotherapy Planning. J Breast Health 2014;10:83-7. [PMID: 28331649 DOI: 10.5152/tjbh.2014.1772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Sharifi H, McDonald GC, Lee JK, Ajlouni MI, Chetty IJ, Zhong H. Four-dimensional computed tomography-based biomechanical measurements of pulmonary function and their correlation with clinical outcome for lung stereotactic body radiation therapy patients. Quant Imaging Med Surg 2019;9:1278-87. [PMID: 31448213 DOI: 10.21037/qims.2019.07.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Scott JG, Sedor G, Scarborough JA, Kattan MW, Peacock J, Grass GD, Mellon EA, Thapa R, Schell M, Waller A, Poppen S, Andl G, Teer JK, Eschrich SA, Dilling TJ, Dalton WS, Harrison LB, Fox T, Torres-roca JF. Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC. Journal of Thoracic Oncology 2021;16:428-38. [DOI: 10.1016/j.jtho.2020.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
124 Qiu B, Aili A, Xue L, Jiang P, Wang J. Advances in Radiobiology of Stereotactic Ablative Radiotherapy. Front Oncol 2020;10:1165. [PMID: 32850333 DOI: 10.3389/fonc.2020.01165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Boon IS, Au Yong TPT, Boon CS. Radiotherapy for COVID-19: Primum non nocere. Radiother Oncol 2020;149:236-7. [PMID: 32505723 DOI: 10.1016/j.radonc.2020.05.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
126 Phillips I, Ezhil V, Hussein M, South C, Nisbet A, Alobaidli S, Prakash V, Ajaz M, Wang H, Evans P. Textural analysis and lung function study: Predicting lung fitness for radiotherapy from a CT scan. BJR Open 2019;1:20180001. [PMID: 33178905 DOI: 10.1259/bjro.20180001] [Reference Citation Analysis]
127 Wirsdörfer F, de Leve S, Jendrossek V. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity? Int J Mol Sci 2018;20:E24. [PMID: 30577587 DOI: 10.3390/ijms20010024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
128 Ghita M, Dunne VL, McMahon SJ, Osman SO, Small DM, Weldon S, Taggart CC, McGarry CK, Hounsell AR, Graves EE, Prise KM, Hanna GG, Butterworth KT. Preclinical Evaluation of Dose-Volume Effects and Lung Toxicity Occurring In and Out-of-Field. Int J Radiat Oncol Biol Phys 2019;103:1231-40. [PMID: 30552964 DOI: 10.1016/j.ijrobp.2018.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
129 Cella L, D'Avino V, Palma G, Conson M, Liuzzi R, Picardi M, Pressello MC, Boboc GI, Battistini R, Donato V, Pacelli R. Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung. Radiother Oncol 2015;117:36-43. [PMID: 26277435 DOI: 10.1016/j.radonc.2015.07.051] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
130 Langendijk JA, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach. Radiotherapy and Oncology 2013;107:267-73. [DOI: 10.1016/j.radonc.2013.05.007] [Cited by in Crossref: 275] [Cited by in F6Publishing: 249] [Article Influence: 30.6] [Reference Citation Analysis]
131 Essers M, Poortmans PM, Verschueren K, Hol S, Cobben DC. Should breathing adapted radiotherapy also be applied for right-sided breast irradiation? Acta Oncol 2016;55:460-5. [PMID: 26503610 DOI: 10.3109/0284186X.2015.1102321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Keffer S, Guy CL, Weiss E. Fatal Radiation Pneumonitis: Literature Review and Case Series. Adv Radiat Oncol 2020;5:238-49. [PMID: 32280824 DOI: 10.1016/j.adro.2019.08.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
133 Sumida I, Yamaguchi H, Das IJ, Kizaki H, Aboshi K, Tsujii M, Yamada Y, Tamari K, Suzuki O, Seo Y, Isohashi F, Yoshioka Y, Ogawa K. Evaluation of the radiobiological gamma index with motion interplay in tangential IMRT breast treatment. J Radiat Res 2016;57:691-701. [PMID: 27534793 DOI: 10.1093/jrr/rrw073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
134 Mihaylov IB. New approach in lung cancer radiotherapy offers better normal tissue sparing. Radiother Oncol 2016;121:316-21. [PMID: 27692398 DOI: 10.1016/j.radonc.2016.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
135 Shaverdian N, Thor M, Shepherd AF, Offin MD, Jackson A, Wu AJ, Gelblum DY, Yorke ED, Simone CB 2nd, Chaft JE, Hellmann MD, Gomez DR, Rimner A, Deasy JO. Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab. Cancer Med 2020;9:4622-31. [PMID: 32372571 DOI: 10.1002/cam4.3113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
136 Chargari C, Riet F, Mazevet M, Morel E, Lepechoux C, Deutsch E. Complications of thoracic radiotherapy. Presse Med 2013;42:e342-51. [PMID: 23972736 DOI: 10.1016/j.lpm.2013.06.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
137 Diot Q, Marks LB, Bentzen SM, Senan S, Kavanagh BD, Lawrence MV, Miften M, Palma DA. Comparison of Radiation-Induced Normal Lung Tissue Density Changes for Patients From Multiple Institutions Receiving Conventional or Hypofractionated Treatments. International Journal of Radiation Oncology*Biology*Physics 2014;89:626-32. [DOI: 10.1016/j.ijrobp.2014.03.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
138 Sutherland JG, Furutani KM, Thomson RM. Monte Carlo calculated doses to treatment volumes and organs at risk for permanent implant lung brachytherapy. Phys Med Biol 2013;58:7061-80. [PMID: 24051987 DOI: 10.1088/0031-9155/58/20/7061] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
139 Farr KP, Kallehauge JF, Møller DS, Khalil AA, Kramer S, Bluhme H, Morsing A, Grau C. Inclusion of functional information from perfusion SPECT improves predictive value of dose–volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study. Radiotherapy and Oncology 2015;117:9-16. [DOI: 10.1016/j.radonc.2015.08.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
140 Shen TL, Liu MN, Zhang Q, Feng W, Yu W, Fu XL, Cai XW. The positive role of vitronectin in radiation induced lung toxicity: the in vitro and in vivo mechanism study. J Transl Med 2018;16:100. [PMID: 29661186 DOI: 10.1186/s12967-018-1474-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
141 Napieralska A, Miszczyk L, Blamek S. Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms. Radiol Oncol 2016;50:409-17. [PMID: 27904449 DOI: 10.1515/raon-2016-0046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
142 Chen CC, Yeh HZ, Chang CS, Ko CW, Lien HC, Wu CY, Hung SW. Transarterial embolization of metastatic mediastinal hepatocellular carcinoma. World J Gastroenterol 2013; 19(22): 3512-3516 [PMID: 23801848 DOI: 10.3748/wjg.v19.i22.3512] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
143 Nichols D, Boyle TA, Noyes D, Latifi K, Feygelman V, Jackson I, Vujaskovic Z, Antonia S, Perez BA. Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis. J Thorac Dis 2018;10:6254-60. [PMID: 30622798 DOI: 10.21037/jtd.2018.10.01] [Reference Citation Analysis]
144 Defraene G, van Elmpt W, Crijns W, De Ruysscher D. Regional variability in radiation-induced lung damage can be predicted by baseline CT numbers. Radiotherapy and Oncology 2017;122:300-6. [DOI: 10.1016/j.radonc.2016.11.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
145 Li R, Roy A, Bice N, Kirby N, Fakhreddine M, Papanikolaou N. Managing tumor changes during radiotherapy using a deep learning model. Med Phys 2021. [PMID: 33959978 DOI: 10.1002/mp.14925] [Reference Citation Analysis]
146 Oh IJ, Ahn SJ. Multidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision. Radiat Oncol J 2017;35:16-24. [PMID: 28395501 DOI: 10.3857/roj.2017.00108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
147 Lee H, Pursley J, Lu HM, Adams J, DeLaney T, Chen YL, Jee KW. A proof of concept treatment planning study of gated proton radiotherapy for cardiac soft tissue sarcoma. Phys Imaging Radiat Oncol 2021;19:78-84. [PMID: 34368473 DOI: 10.1016/j.phro.2021.06.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Li Y, Rodrigues A, Li T, Yuan L, Yin FF, Wu QJ. Impact of dose calculation accuracy during optimization on lung IMRT plan quality. J Appl Clin Med Phys 2015;16:5137. [PMID: 25679172 DOI: 10.1120/jacmp.v16i1.5137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
149 Banfill K, Giuliani M, Aznar M, Franks K, McWilliam A, Schmitt M, Sun F, Vozenin MC, Faivre Finn C; IASLC Advanced Radiation Technology committee. Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions. J Thorac Oncol 2021;16:216-27. [PMID: 33278607 DOI: 10.1016/j.jtho.2020.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
150 Bujold A, Craig T, Jaffray D, Dawson LA. Image-guided radiotherapy: has it influenced patient outcomes? Semin Radiat Oncol 2012;22:50-61. [PMID: 22177878 DOI: 10.1016/j.semradonc.2011.09.001] [Cited by in Crossref: 98] [Cited by in F6Publishing: 75] [Article Influence: 9.8] [Reference Citation Analysis]
151 Kong FM, Wang S. Nondosimetric risk factors for radiation-induced lung toxicity. Semin Radiat Oncol 2015;25:100-9. [PMID: 25771414 DOI: 10.1016/j.semradonc.2014.12.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
152 Biau J, Bellière A, Verrelle P, Lapeyre M. Excluding either gross tumor volume or planning target volume from the normal lung volume in lung cancer irradiation: Evaluation of the dosimetric impact. Pract Radiat Oncol 2013;3:e79-85. [PMID: 24674324 DOI: 10.1016/j.prro.2012.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
153 Song JH, Son SH, Kay CS, Jang HS. Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy. Oncotarget. 2015;6:33952-33960. [PMID: 26376679 DOI: 10.18632/oncotarget.5581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
154 Vogelius IR, Petersen J, Bentzen SM. Harnessing data science to advance radiation oncology. Mol Oncol 2020;14:1514-28. [PMID: 32255249 DOI: 10.1002/1878-0261.12685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
155 Bourbonne V, Lucia F, Jaouen V, Bert J, Rehn M, Pradier O, Visvikis D, Schick U. Development and prospective validation of a spatial dose pattern based model predicting acute pulmonary toxicity in patients treated with volumetric arc-therapy for locally advanced lung cancer. Radiother Oncol 2021;164:43-9. [PMID: 34547351 DOI: 10.1016/j.radonc.2021.09.008] [Reference Citation Analysis]
156 Paganetti H, van Luijk P. Biological considerations when comparing proton therapy with photon therapy. Semin Radiat Oncol 2013;23:77-87. [PMID: 23473684 DOI: 10.1016/j.semradonc.2012.11.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
157 Defraene G, La Fontaine M, van Kranen S, Reymen B, Belderbos J, Sonke JJ, De Ruysscher D. Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume. Int J Radiat Oncol Biol Phys 2018;102:642-50. [PMID: 30244882 DOI: 10.1016/j.ijrobp.2018.06.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
158 Lopez B, Mahvash A, Lam MGEH, Kappadath SC. Calculation of lung mean dose and quantification of error for 90 Y‐microsphere radioembolization using 99m Tc‐MAA SPECT/CT and diagnostic chest CT. Med Phys 2019;46:3929-40. [DOI: 10.1002/mp.13575] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Kanehira T, Matsuura T, Takao S, Matsuzaki Y, Fujii Y, Fujii T, Ito YM, Miyamoto N, Inoue T, Katoh N, Shimizu S, Umegaki K, Shirato H. Impact of Real-Time Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study. Int J Radiat Oncol Biol Phys 2017;97:173-81. [PMID: 27856039 DOI: 10.1016/j.ijrobp.2016.09.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
160 O’brien RT, Cooper BJ, Keall PJ. Optimizing 4D cone beam computed tomography acquisition by varying the gantry velocity and projection time interval. Phys Med Biol 2013;58:1705-23. [DOI: 10.1088/0031-9155/58/6/1705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
161 Bernchou U, Hansen O, Schytte T, Bertelsen A, Hope A, Moseley D, Brink C. Prediction of lung density changes after radiotherapy by cone beam computed tomography response markers and pre-treatment factors for non-small cell lung cancer patients. Radiotherapy and Oncology 2015;117:17-22. [DOI: 10.1016/j.radonc.2015.07.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
162 Deshmukh S, Sharan K, Fernandes DJ, Srinivasa VM, Yathiraj PH, Singh A, Reddy A. A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer. J Clin Diagn Res 2016;10:XC05-8. [PMID: 27630936 DOI: 10.7860/JCDR/2016/20477.8146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Hjelstuen MH, Mjaaland I, Vikström J, Dybvik KI. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol 2012;51:333-44. [PMID: 22171587 DOI: 10.3109/0284186X.2011.618510] [Cited by in Crossref: 92] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
164 Wanet M, Sterpin E, Janssens G, Delor A, Lee JA, Geets X. Validation of the mid-position strategy for lung tumors in helical TomoTherapy. Radiotherapy and Oncology 2014;110:529-37. [DOI: 10.1016/j.radonc.2013.10.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
165 Hoffmann L, Alber M, Jensen MF, Holt MI, Møller DS. Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage. Radiother Oncol 2017;122:400-5. [PMID: 28043645 DOI: 10.1016/j.radonc.2016.12.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
166 Szejniuk WM, Nielsen MS, Takács-Szabó Z, Pawlowski J, Al-Saadi SS, Maidas P, Bøgsted M, McCulloch T, Frøkjær JB, Falkmer UG, Røe OD. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis. Radiat Oncol 2021;16:131. [PMID: 34266462 DOI: 10.1186/s13014-021-01857-8] [Reference Citation Analysis]
167 Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U. Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? PLoS One 2017;12:e0185350. [PMID: 28957436 DOI: 10.1371/journal.pone.0185350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
168 Liang B, Yan H, Tian Y, Chen X, Yan L, Zhang T, Zhou Z, Wang L, Dai J. Dosiomics: Extracting 3D Spatial Features From Dose Distribution to Predict Incidence of Radiation Pneumonitis. Front Oncol 2019;9:269. [PMID: 31032229 DOI: 10.3389/fonc.2019.00269] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
169 Desideri I, Loi M, Francolini G, Becherini C, Livi L, Bonomo P. Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art. Front Oncol 2020;10:1708. [PMID: 33117669 DOI: 10.3389/fonc.2020.01708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
170 De Ruysscher D, Defraene G, Ramaekers BLT, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. Radiother Oncol 2016;121:440-6. [PMID: 27979370 DOI: 10.1016/j.radonc.2016.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
171 Yang J, Chu D, Dong L, Court LE. Advantages of simulating thoracic cancer patients in an upright position. Pract Radiat Oncol 2014;4:e53-8. [PMID: 24621432 DOI: 10.1016/j.prro.2013.04.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
172 Frederick A, Roumeliotis M, Grendarova P, Quirk S. Performance of a knowledge-based planning model for optimizing intensity-modulated radiotherapy plans for partial breast irradiation. J Appl Clin Med Phys 2021. [PMID: 34936195 DOI: 10.1002/acm2.13506] [Reference Citation Analysis]
173 Thor M, Deasy J, Iyer A, Bendau E, Fontanella A, Apte A, Yorke E, Rimner A, Jackson A. Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models. Radiother Oncol 2019;138:45-51. [PMID: 31146070 DOI: 10.1016/j.radonc.2019.05.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
174 Stuschke M, Kaiser A, Pöttgen C, Lübcke W, Farr J. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. Radiotherapy and Oncology 2012;104:45-51. [DOI: 10.1016/j.radonc.2012.03.017] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 7.3] [Reference Citation Analysis]
175 Hoffmann L, Holt MI, Knap MM, Khalil AA, Møller DS. Anatomical landmarks accurately determine interfractional lymph node shifts during radiotherapy of lung cancer patients. Radiotherapy and Oncology 2015;116:64-9. [DOI: 10.1016/j.radonc.2015.06.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
176 Coates J, Ybarra N, El Naqa I. Non-invasive whole-body plethysmograph for assessment and prediction of radiation-induced lung injury using simultaneously acquired nitric oxide and lung volume measurements. Physiol Meas 2014;35:1737-50. [PMID: 25119582 DOI: 10.1088/0967-3334/35/9/1737] [Reference Citation Analysis]
177 Anzic M, Marinko T. Effect of Adjuvant Hormonal Therapy on the Development of Pulmonary Fibrosis after Postoperative Radiotherapy for Breast Cancer. J Breast Cancer 2020;23:449-59. [PMID: 33154822 DOI: 10.4048/jbc.2020.23.e48] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 De Ruysscher D, Faivre-Finn C, Le Pechoux C, Peeters S, Belderbos J. High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. Lancet Oncol. 2014;15:e620-e624. [PMID: 25456380 DOI: 10.1016/s1470-2045(14)70345-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 6.1] [Reference Citation Analysis]
179 Appelt AL, Vogelius IR. A method to adjust radiation dose-response relationships for clinical risk factors. Radiother Oncol 2012;102:352-4. [PMID: 21981874 DOI: 10.1016/j.radonc.2011.08.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
180 Kabolizadeh P, Kalash R, Huq MS, Greenberger JS, Heron DE, Beriwal S. Dosimetric Definitions of Total Lung Volumes in Calculating Parameters Predictive for Radiation-induced Pneumonitis. American Journal of Clinical Oncology 2015;38:401-4. [DOI: 10.1097/coc.0b013e3182a2588f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Aras S, İkizceli T, Aktan M. Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy (3D-CRT) and Intensity Modulated Radiotherapy Techniques (IMRT) with Radiotherapy Dose Simulations for Left-Sided Mastectomy Patients. Eur J Breast Health 2019;15:85-9. [PMID: 31001609 DOI: 10.5152/ejbh.2019.4619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
182 Wang W, Xu Y, Schipper M, Matuszak MM, Ritter T, Cao Y, Ten Haken RK, Kong FM. Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 2013;86:956-63. [PMID: 23845844 DOI: 10.1016/j.ijrobp.2013.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
183 Nahum AE, Uzan J. (Radio)biological optimization of external-beam radiotherapy. Comput Math Methods Med 2012;2012:329214. [PMID: 23251227 DOI: 10.1155/2012/329214] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
184 Qiu J, Liu Z, Yang B, Hou X, Zhang F. Low-dose-area-constrained helical TomoTherapy-based whole breast radiotherapy and dosimetric comparison with tangential field-in-field IMRT. Biomed Res Int 2013;2013:513708. [PMID: 24024197 DOI: 10.1155/2013/513708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
185 Yamashita H, Takahashi W, Haga A, Nakagawa K. Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World J Radiol 2014; 6(9): 708-715 [PMID: 25276313 DOI: 10.4329/wjr.v6.i9.708] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
186 Tyler Watkins W, Moore JA, Hugo GD, Siebers JV. Dose to mass for evaluation and optimization of lung cancer radiation therapy. Radiother Oncol 2017;125:344-50. [PMID: 29031611 DOI: 10.1016/j.radonc.2017.09.002] [Reference Citation Analysis]
187 Miles EF, Jacimore LL, Nelson JW. Aggressive Palliation in Extensive Stage Small Cell Lung Cancer, Practice Guidelines versus Clinical Practice: A Case Report and Review of the Literature. Lung Cancer Int 2011;2011:659807. [PMID: 26316931 DOI: 10.4061/2011/659807] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
188 Xu S, Liu C, Ji HL. Concise Review: Therapeutic Potential of the Mesenchymal Stem Cell Derived Secretome and Extracellular Vesicles for Radiation-Induced Lung Injury: Progress and Hypotheses. Stem Cells Transl Med. 2019;8:344-354. [PMID: 30618085 DOI: 10.1002/sctm.18-0038] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
189 Liljegren A, Unukovych D, Gagliardi G, Bjöhle J, Wickman M, Johansson H, Sandelin K. No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction. Radiat Oncol 2014;9:14. [PMID: 24406085 DOI: 10.1186/1748-717X-9-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
190 Katsui K, Ogata T, Watanabe K, Katayama N, Kuroda M, Kiura K, Hiraki T, Maeda Y, Toyooka S, Kanazawa S. Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters. Cancer Med 2020;9:4540-9. [PMID: 32364685 DOI: 10.1002/cam4.3093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
191 Nagaraj J, Veluraja K. Is Synchronous Bilateral Breast Irradiation Using Flattening Filter-Free Beam-Based Volumetric-Modulated Arc Therapy Beneficial? A Dosimetric Study. J Med Phys 2020;45:226-33. [PMID: 33953498 DOI: 10.4103/jmp.JMP_32_20] [Reference Citation Analysis]
192 Grassberger C, Dowdell S, Lomax A, Sharp G, Shackleford J, Choi N, Willers H, Paganetti H. Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2013;86:380-6. [PMID: 23462423 DOI: 10.1016/j.ijrobp.2013.01.024] [Cited by in Crossref: 129] [Cited by in F6Publishing: 114] [Article Influence: 14.3] [Reference Citation Analysis]
193 Lia K, Bruland ØS, Randem HL, Aksnes LH, Poulsen JP, Taksdal I, Sundby Hall K. Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma. J Bone Oncol 2013;2:174-9. [PMID: 26909289 DOI: 10.1016/j.jbo.2013.09.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
194 Wijsman R, Dankers FJWM, Troost EGC, Hoffmann AL, van der Heijden EHFM, de Geus-Oei LF, Bussink J. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 2017;99:434-41. [PMID: 28871994 DOI: 10.1016/j.ijrobp.2017.04.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
195 Morias S, Marcu LG, Short M, Giles E, Bezak E. Do SABR-related toxicities for lung cancer depend on treatment delivery? Crit Rev Oncol Hematol 2018;129:67-78. [PMID: 30097239 DOI: 10.1016/j.critrevonc.2018.06.014] [Reference Citation Analysis]
196 Gomez DR, Komaki R. Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies. Cancers (Basel) 2012;4:307-22. [PMID: 24213242 DOI: 10.3390/cancers4010307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
197 Kong FS, Moiseenko V, Zhao J, Milano MT, Li L, Rimner A, Das S, Li XA, Miften M, Liao Z, Martel M, Bentzen SM, Jackson A, Grimm J, Marks LB, Yorke E. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma? Int J Radiat Oncol Biol Phys 2021;110:172-87. [PMID: 30496880 DOI: 10.1016/j.ijrobp.2018.11.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
198 Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. Clin Oncol (R Coll Radiol) 2015;27:579-87. [PMID: 26166774 DOI: 10.1016/j.clon.2015.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
199 Keall PJ, Sawant A, Berbeco RI, Booth JT, Cho B, Cerviño LI, Cirino E, Dieterich S, Fast MF, Greer PB, Munck Af Rosenschöld P, Parikh PJ, Poulsen PR, Santanam L, Sherouse GW, Shi J, Stathakis S. AAPM Task Group 264: The safe clinical implementation of MLC tracking in radiotherapy. Med Phys 2021;48:e44-64. [PMID: 33260251 DOI: 10.1002/mp.14625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
200 Barry A, Rock K, Sole C, Rahman M, Pintilie M, Lee G, Fyles A, Koch CA. The impact of active breathing control on internal mammary lymph node coverage and normal tissue exposure in breast cancer patients planned for left-sided postmastectomy radiation therapy. Practical Radiation Oncology 2017;7:228-33. [DOI: 10.1016/j.prro.2016.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
201 Giaddui T, Chen W, Yu J, Lin L, Simone CB 2nd, Yuan L, Gong YU, Wu QJ, Mohan R, Zhang X, Bluett JB, Gillin M, Moore K, O'Meara E, Presley J, Bradley JD, Liao Z, Galvin J, Xiao Y. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. Radiat Oncol 2016;11:66. [PMID: 27142674 DOI: 10.1186/s13014-016-0640-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 50] [Article Influence: 6.5] [Reference Citation Analysis]
202 Chira C, Kirova YM, Liem X, Campana F, Peurien D, Amessis M, Fournier-Bidoz N, Pierga JY, Dendale R, Bey P, Fourquet A. Helical tomotherapy for inoperable breast cancer: a new promising tool. Biomed Res Int 2013;2013:264306. [PMID: 24078909 DOI: 10.1155/2013/264306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
203 Li F, Liu H, Wu H, Liang S, Xu Y. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy. Radiat Oncol 2021;16:70. [PMID: 33849579 DOI: 10.1186/s13014-021-01798-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Delgado BD, Enguix-riego MV, Fernández de Bobadilla JC, Herrero Rivera D, Nieto-guerrero Gómez JM, Praena-fernández JM, Rivin del Campo E, Ortiz Gordillo MJ, Fernandez Fernandez MDC, Lopez Guerra JL. Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer. Radiotherapy and Oncology 2019;135:161-9. [DOI: 10.1016/j.radonc.2019.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
205 Fried DV, Das SK, Marks LB. Imaging Radiation-Induced Normal Tissue Injury to Quantify Regional Dose Response. Semin Radiat Oncol 2017;27:325-31. [PMID: 28865515 DOI: 10.1016/j.semradonc.2017.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Lin KH, Hsu CX, Wang SY, Mok GSP, Chang CH, Tien HJ, Shueng PW, Wu TH. Volume-based algorithm of lung dose optimization in novel dynamic arc radiotherapy for esophageal cancer. Sci Rep 2021;11:4360. [PMID: 33623071 DOI: 10.1038/s41598-021-83682-3] [Reference Citation Analysis]
207 Badiyan SN, Shah C, Arthur D, Khan AJ, Freedman G, Poppe MM, Vicini FA. Hypofractionated regional nodal irradiation for breast cancer: Examining the data and potential for future studies. Radiotherapy and Oncology 2014;110:39-44. [DOI: 10.1016/j.radonc.2013.12.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
208 Diao K, Chen YH, Catalano PJ, Lee S, Milani N, Killoran JH, Baldini EH, Chen AB, Kozono DE, Mak RH. Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother Oncol 2017;125:301-9. [PMID: 29102264 DOI: 10.1016/j.radonc.2017.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
209 Christodoulou M, Mccloskey P, Stones N, Bayman N, Burt P, Chittalia A, Harris M, Lee L, Pemberton L, Sheikh H, Swindell R, Faivre-finn C. Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer. Radiotherapy and Oncology 2014;112:244-9. [DOI: 10.1016/j.radonc.2014.07.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
210 van Diessen JN, Kwint M, Sonke J, Walraven I, Stam B, de Langen AJ, Knegjens J, Belderbos JS. Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients. Radiotherapy and Oncology 2020;143:66-72. [DOI: 10.1016/j.radonc.2019.07.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
211 Nemoto T, Futakami N, Yagi M, Kumabe A, Takeda A, Kunieda E, Shigematsu N. Efficacy evaluation of 2D, 3D U-Net semantic segmentation and atlas-based segmentation of normal lungs excluding the trachea and main bronchi. J Radiat Res 2020;61:257-64. [PMID: 32043528 DOI: 10.1093/jrr/rrz086] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
212 Wuschner AE, Wallat EM, Flakus MJ, Shanmuganayagam D, Meudt J, Christensen GE, Reinhardt JM, Miller JR, Lawless MJ, Baschnagel AM, Bayouth JE. Radiation-induced Hounsfield unit change correlates with dynamic CT perfusion better than 4DCT-based ventilation measures in a novel-swine model. Sci Rep 2021;11:13156. [PMID: 34162987 DOI: 10.1038/s41598-021-92609-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Huang P, Yan H, Hu Z, Liu Z, Tian Y, Dai J. Predicting radiation pneumonitis with fuzzy clustering neural network using 4DCT ventilation image based dosimetric parameters. Quant Imaging Med Surg 2021;11:4731-41. [PMID: 34888185 DOI: 10.21037/qims-20-1095] [Reference Citation Analysis]
214 Lee YK, Brooks CJ, Bedford JL, Warrington AP, Saran FH. In Reply to Dr. Saini et al. International Journal of Radiation Oncology*Biology*Physics 2012;82:495-6. [DOI: 10.1016/j.ijrobp.2011.07.023] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
215 Péguret N, Ozsahin M, Zeverino M, Belmondo B, Durham AD, Lovis A, Simons J, Long O, Duclos F, Prior J, Denys A, Beigelman C, Sozzi WJ, Grant K, Gautier-Dechaud V, Peters S, Vienne M, Moeckli R, Bourhis J. Apnea-like suppression of respiratory motion: First evaluation in radiotherapy. Radiother Oncol 2016;118:220-6. [PMID: 26979264 DOI: 10.1016/j.radonc.2015.10.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
216 Ma JT, Sun L, Sun X, Xiong ZC, Liu Y, Zhang SL, Huang LT, Han CB. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy? Radiat Oncol 2017;12:34. [PMID: 28143532 DOI: 10.1186/s13014-017-0772-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
217 Eberhardt WE, De Ruysscher D, Weder W, Le Péchoux C, De Leyn P, Hoffmann H, Westeel V, Stahel R, Felip E, Peters S. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol. 2015;26:1573-1588. [PMID: 25897013 DOI: 10.1093/annonc/mdv187] [Cited by in Crossref: 187] [Cited by in F6Publishing: 195] [Article Influence: 26.7] [Reference Citation Analysis]
218 Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M. Regional Normal Lung Tissue Density Changes in Patients Treated With Stereotactic Body Radiation Therapy for Lung Tumors. International Journal of Radiation Oncology*Biology*Physics 2012;84:1024-30. [DOI: 10.1016/j.ijrobp.2011.11.080] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
219 Rosca F, Kirk M, Soto D, Sall W, Mcintyre J. Reducing the low-dose lung radiation for central lung tumors by restricting the IMRT beams and arc arrangement. Medical Dosimetry 2012;37:280-6. [DOI: 10.1016/j.meddos.2011.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
220 Moiseenko V, Grimm J, Yorke E, Jackson A, Yip A, Huynh-Le MP, Mahadevan A, Forster K, Milano MT, Hattangadi-Gluth JA. Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design. Cureus 2020;12:e10808. [PMID: 33163312 DOI: 10.7759/cureus.10808] [Reference Citation Analysis]
221 Salem A, Mohamad I, Dayyat A, Kanaa'n H, Sarhan N, Roujob I, Salem AF, Afifi S, Jaradat I, Mubiden R, Almousa A. Combined photon-electron beams in the treatment of the supraclavicular lymph nodes in breast cancer: A novel technique that achieves adequate coverage while reducing lung dose. Med Dosim 2015;40:210-7. [PMID: 25595492 DOI: 10.1016/j.meddos.2014.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 Wanet M, Delor A, Hanin FX, Ghaye B, Van Maanen A, Remouchamps V, Clermont C, Goossens S, Lee JA, Janssens G, Bol A, Geets X. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging. Strahlenther Onkol 2017;193:812-22. [PMID: 28733723 DOI: 10.1007/s00066-017-1168-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
223 Hau E, Rains M, Browne L, Muirhead R, Yeghiaian-alvandi R. Minimal benefit of respiratory-gated radiation therapy in the management of thoracic malignancy: Minimal benefit to respiratory gating. Journal of Medical Imaging and Radiation Oncology 2013;57:704-12. [DOI: 10.1111/1754-9485.12088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
224 Paganetti H, Grassberger C, Sharp GC. Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC. Semin Radiat Oncol 2021;31:162-9. [PMID: 33610274 DOI: 10.1016/j.semradonc.2020.11.004] [Reference Citation Analysis]
225 Selek U, Bölükbaşı Y, Welsh JW, Topkan E. Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer. Balkan Med J 2014;31:286-94. [PMID: 25667781 DOI: 10.5152/balkanmedj.2014.14529] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
226 Shrimali RK, Chakraborty S, Bhattacharyya T, Mallick I, Achari RB, Prasath S, Arun B, Mahata A, Vidhya Shree M, Vishnupriya E, Chatterjee S. Development and validation of a decision support tool to select IMRT as radiotherapy treatment planning modality for patients with locoregionally advanced non-small cell lung cancers (NSCLC). Br J Radiol 2019;92:20180431. [PMID: 30387364 DOI: 10.1259/bjr.20180431] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
227 Selvaraj J, Lebesque J, Hope A, Guckenberger M, Werner-wasik M, Peulen H, Giuliani M, Mantel F, Belderbos J, Grills I, Sonke J. Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose–effect relationship for lung perfusion loss. Radiotherapy and Oncology 2019;132:142-7. [DOI: 10.1016/j.radonc.2018.12.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
228 Esquinas PL, Shinto A, Kamaleshwaran KK, Joseph J, Celler A. Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans. EJNMMI Phys 2018;5:30. [PMID: 30523435 DOI: 10.1186/s40658-018-0227-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
229 El Naqa I, Brock K, Yu Y, Langen K, Klein EE. On the Fuzziness of Machine Learning, Neural Networks, and Artificial Intelligence in Radiation Oncology. International Journal of Radiation Oncology*Biology*Physics 2018;100:1-4. [DOI: 10.1016/j.ijrobp.2017.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
230 Deseyne P, Speleers B, De Neve W, Boute B, Paelinck L, Van Hoof T, Van de Velde J, Van Greveling A, Monten C, Post G, Depypere H, Veldeman L. Whole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer. Radiat Oncol 2017;12:89. [PMID: 28549483 DOI: 10.1186/s13014-017-0828-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
231 McNamara AL, Hall DC, Shusharina N, Liu A, Wei X, Ajdari A, Mohan R, Liao Z, Paganetti H. Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial. Radiother Oncol 2020;147:8-14. [PMID: 32224318 DOI: 10.1016/j.radonc.2020.02.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
232 Péchoux CL, Mercier O, Belemsagha D, Bouaita R, Besse B, Fadel E. Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer. EJC Suppl 2013;11:123-30. [PMID: 26217121 DOI: 10.1016/j.ejcsup.2013.07.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
233 Hawkins MA, Bedford JL, Warrington AP, Tait DM. Volumetric modulated arc therapy planning for distal oesophageal malignancies. Br J Radiol. 2012;85:44-52. [PMID: 21427179 DOI: 10.1259/bjr/25428720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
234 Son SH, Choi KH, Kim SW. Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer. PLoS One 2017;12:e0173552. [PMID: 28273157 DOI: 10.1371/journal.pone.0173552] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Jain V, Berman AT. Radiation Pneumonitis: Old Problem, New Tricks. Cancers (Basel) 2018;10:E222. [PMID: 29970850 DOI: 10.3390/cancers10070222] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
236 Kim K, Lee J, Cho Y, Chung SY, Lee JJB, Lee CG, Cho J. Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy. Radiat Oncol J 2017;35:163-71. [PMID: 28712275 DOI: 10.3857/roj.2017.00066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
237 Itonaga T, Sugahara S, Mikami R, Saito T, Yamada T, Kurooka M, Shiraishi S, Okubo M, Saito K. Evaluation of the relationship between the range of radiation-induced lung injury on CT images after IMRT for stage I lung cancer and dosimetric parameters. Ann Med 2021;53:267-73. [PMID: 33430616 DOI: 10.1080/07853890.2020.1869297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Yeo SG. Palliative radiotherapy for thoracic spine metastases: Dosimetric advantage of three-dimensional conformal plans. Oncol Lett 2015;10:497-501. [PMID: 26171058 DOI: 10.3892/ol.2015.3205] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
239 Zhang Z, Zhou J, Verma V, Liu X, Wu M, Yu J, Chen D. Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury. Front Immunol 2021;12:774807. [PMID: 34925345 DOI: 10.3389/fimmu.2021.774807] [Reference Citation Analysis]
240 Thompson MR, Dumane VA, Lazarev SA, Zia Y, Rosenzweig KE. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs. Pract Radiat Oncol 2019;9:e331-7. [PMID: 30654090 DOI: 10.1016/j.prro.2018.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
241 Møller DS, Holt MI, Alber M, Tvilum M, Khalil AA, Knap MM, Hoffmann L. Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose. Radiotherapy and Oncology 2016;121:32-8. [DOI: 10.1016/j.radonc.2016.08.019] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
242 Briere TM, Krafft S, Liao Z, Martel MK. Lung Size and the Risk of Radiation Pneumonitis. Int J Radiat Oncol Biol Phys 2016;94:377-84. [PMID: 26675062 DOI: 10.1016/j.ijrobp.2015.10.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
243 Goto S, Murakami M, Kawabe M, Iwasaki R, Heishima K, Sakai H, Mori T. Hypofractionated radiation therapy in the treatment of canine thymoma: Retrospective study of eight cases. Vet Radiol Ultrasound 2017;58:613-20. [DOI: 10.1111/vru.12525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
244 Tucker SL, Liao Z, Dinh J, Bian SX, Mohan R, Martel MK, Grosshans DR. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort. Acta Oncol 2014;53:590-6. [PMID: 23992110 DOI: 10.3109/0284186X.2013.831185] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
245 Guerrero M, Fellows Z, Mohindra P, Badiyan S, Lamichhane N, Snider JW, Chen S. Multicriteria optimization: Site-specific class solutions for VMAT plans. Medical Dosimetry 2020;45:7-13. [DOI: 10.1016/j.meddos.2019.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
246 Murai T, Shibamoto Y, Manabe Y, Murata R, Sugie C, Hayashi A, Ito H, Miyoshi Y. Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode. Radiat Oncol 2013;8. [DOI: 10.1186/1748-717x-8-68] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
247 Kharofa J, Gore E. Symptomatic Radiation Pneumonitis in Elderly Patients Receiving Thoracic Irradiation. Clinical Lung Cancer 2013;14:283-7. [DOI: 10.1016/j.cllc.2012.10.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
248 Chaikh A, Calugaru V, Bondiau P, Thariat J, Balosso J. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans. International Journal of Radiation Biology 2018;94:789-97. [DOI: 10.1080/09553002.2018.1486516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
249 Wang X, Xu F, Wei Y. [Advances of precise radiotherapy for lung cancer]. Zhongguo Fei Ai Za Zhi. 2011;14:894-899. [PMID: 22104227 DOI: 10.3779/j.issn.1009-3419.2011.11.12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
250 Bailey DW, Wang IZ, Lakeman T, Hales LD, Singh AK, Podgorsak MB. TBI lung dose comparisons using bilateral and anteroposterior delivery techniques and tissue density corrections. J Appl Clin Med Phys 2015;16:5293. [PMID: 26103198 DOI: 10.1120/jacmp.v16i2.5293] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
251 Xie Y, Bourgeois D, Guo B, Zhang R. Postmastectomy radiotherapy for left-sided breast cancer patients: Comparison of advanced techniques. Med Dosim 2020;45:34-40. [PMID: 31129035 DOI: 10.1016/j.meddos.2019.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
252 Farace P, Zucca S, Solla I, Fadda G, Durzu S, Porru S, Meleddu G, Deidda MA, Possanzini M, Orrù S, Lay G. Planning Hybrid Intensity Modulated Radiation Therapy for Whole-breast Irradiation. International Journal of Radiation Oncology*Biology*Physics 2012;84:e115-22. [DOI: 10.1016/j.ijrobp.2012.02.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
253 Jethwa KR, Haddock MG, Tryggestad EJ, Hallemeier CL. The emerging role of proton therapy for esophagus cancer. J Gastrointest Oncol 2020;11:144-56. [PMID: 32175118 DOI: 10.21037/jgo.2019.11.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
254 Wong P, Lambert L, Thanomsack P, Coulombe G, Lambert C, Charpentier AM, Barkati M, Fortin I, Lafontaine J, Roberge D. Quality of Life: A Prospective Randomized Trial of Palliative Volumetric Arc Therapy Versus 3-Dimensional Conventional Radiation Therapy. Int J Radiat Oncol Biol Phys 2021;109:1431-9. [PMID: 33259935 DOI: 10.1016/j.ijrobp.2020.11.061] [Reference Citation Analysis]
255 Harder EM, Park HS, Chen ZJ, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Pract Radiat Oncol 2016;6:e353-9. [PMID: 27156424 DOI: 10.1016/j.prro.2016.01.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
256 Brodin NP, Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Bentzen SM, Specht L. Interactive Decision-Support Tool for Risk-Based Radiation Therapy Plan Comparison for Hodgkin Lymphoma. International Journal of Radiation Oncology*Biology*Physics 2014;88:433-45. [DOI: 10.1016/j.ijrobp.2013.10.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
257 Stoppel G, Eich HT, Matuschek C, Kortmann RD, Meyer F, Martinsson U, Nilsson K, Kristensen I, Vordermark D, Willich N, Christiansen H, Koch R, Steinmann D. Lung toxicity after radiation in childhood: Results of the International Project on Prospective Analysis of Radiotoxicity in Childhood and Adolescence. Radiother Oncol 2017;125:286-92. [PMID: 29050956 DOI: 10.1016/j.radonc.2017.09.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
258 Møller DS, Lutz CM, Khalil AA, Alber M, Holt MI, Kandi M, Schmidt HH, Tvilum M, Appelt A, Knap MM, Hoffmann L. Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy. Radiother Oncol 2022:S0167-8140(22)00065-2. [PMID: 35121030 DOI: 10.1016/j.radonc.2022.01.039] [Reference Citation Analysis]
259 Liang X, Zheng D, Mamalui-Hunter M, Flampouri S, Hoppe BS, Mendenhall N, Li Z. ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer. Pract Radiat Oncol 2019;9:38-48. [PMID: 30138747 DOI: 10.1016/j.prro.2018.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
260 Ratosa I, Jenko A, Oblak I. Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning. Radiol Oncol 2018;52:233-44. [PMID: 30210048 DOI: 10.2478/raon-2018-0026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
261 Waheed A, Butt S, Ishtiaq A, Mansha MA, Mehreen S, Raza M, Yousaf M. Dosimetric Comparison of Whole Breast Radiotherapy Using Field-in-Field and Volumetric Modulated Arc Therapy Techniques in Left-Sided Breast Cancer Patients. Cureus 2021;13:e15732. [PMID: 34285843 DOI: 10.7759/cureus.15732] [Reference Citation Analysis]
262 Hernandez M, Zhang R, Sanders M, Newhauser W. A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy. J Proton Ther. 2015;1. [PMID: 29104948 DOI: 10.14319/jpt.11.9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
263 Cheung JP, Park PC, Court LE, Ronald Zhu X, Kudchadker RJ, Frank SJ, Dong L. A novel dose-based positioning method for CT image-guided proton therapy. Med Phys 2013;40:051714. [PMID: 23635262 DOI: 10.1118/1.4801910] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
264 Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-Induced Lung Injury: Assessment and Management. Chest 2019;156:150-62. [PMID: 30998908 DOI: 10.1016/j.chest.2019.03.033] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 29.0] [Reference Citation Analysis]
265 Liu F, Yorke ED, Belderbos JS, Borst GR, Rosenzweig KE, Lebesque JV, Jackson A. Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols. Int J Radiat Oncol Biol Phys 2013;85:182-9. [PMID: 22560554 DOI: 10.1016/j.ijrobp.2012.03.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
266 Cron KR, Zhu K, Kushwaha DS, Hsieh G, Merzon D, Rameseder J, Chen CC, D'Andrea AD, Kozono D. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One 2013;8:e73710. [PMID: 24040035 DOI: 10.1371/journal.pone.0073710] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
267 Jameson MG, Kumar S, Vinod SK, Metcalfe PE, Holloway LC. Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy. Radiotherapy and Oncology 2014;112:332-6. [DOI: 10.1016/j.radonc.2014.03.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
268 Owen DR, Boonstra PS, Viglianti BL, Balter JM, Schipper MJ, Jackson WC, El Naqa I, Jolly S, Ten Haken RK, Kong FS, Matuszak MM. Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage. Int J Radiat Oncol Biol Phys 2018;102:1265-75. [PMID: 30108006 DOI: 10.1016/j.ijrobp.2018.05.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
269 Smyth LM, Day LR, Woodford K, Rogers PA, Crosbie JC, Senthi S. Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy: A treatment planning study. Physica Medica 2019;60:111-9. [DOI: 10.1016/j.ejmp.2019.03.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
270 Loo SW, Smith S, Promnitz DA, Van Tornout F. Synchronous bilateral squamous cell carcinoma of the lung successfully treated using intensity-modulated radiotherapy. Br J Radiol 2012;85:77-80. [PMID: 21937610 DOI: 10.1259/bjr/64570729] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
271 Ma C, Zhang W, Lu J, Wu L, Wu F, Huang B, Lin Y, Li D. Dosimetric Comparison and Evaluation of Three Radiotherapy Techniques for Use after Modified Radical Mastectomy for Locally Advanced Left-sided Breast Cancer. Sci Rep 2015;5:12274. [PMID: 26194593 DOI: 10.1038/srep12274] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
272 Lancellotta V, Iacco M, Perrucci E, Falcinelli L, Zucchetti C, de Bari B, Saldi S, Aristei C. Comparing four radiotherapy techniques for treating the chest wall plus levels III-IV draining nodes after breast reconstruction. Br J Radiol 2018;91:20160874. [PMID: 29474098 DOI: 10.1259/bjr.20160874] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
273 Morias S, Marcu LG, Short M, Giles E, Potter A, Shepherd J, Gierlach T, Bezak E. Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy. J Oncol 2018;2018:6483626. [PMID: 30402100 DOI: 10.1155/2018/6483626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
274 Hunter B, Crockett C, Faivre-Finn C, Hiley C, Salem A. Re-Irradiation of Recurrent Non-Small Cell Lung Cancer. Semin Radiat Oncol 2021;31:124-32. [PMID: 33610269 DOI: 10.1016/j.semradonc.2020.11.009] [Reference Citation Analysis]
275 Houlihan OA, Rangaswamy G, Dunne M, Rohan C, O'Neill L, Chalke S, Daly P, Gillham C, McArdle O. Deep inspiration breath hold versus free breathing technique in mediastinal radiotherapy for lymphoma. BJR Open 2021;3:20200067. [PMID: 33718767 DOI: 10.1259/bjro.20200067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Palma G, Monti S, Conson M, Pacelli R, Cella L. Normal tissue complication probability (NTCP) models for modern radiation therapy. Semin Oncol 2019;46:210-8. [PMID: 31506196 DOI: 10.1053/j.seminoncol.2019.07.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
277 Kirkby C, Mackenzie M. Response to: Low dose radiation therapy for COVID-19 pneumonia a double-edged sword. Radiother Oncol 2020;147:226. [PMID: 32387544 DOI: 10.1016/j.radonc.2020.04.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Roelofs E, Engelsman M, Rasch C, Persoon L, Qamhiyeh S, de Ruysscher D, Verhaegen F, Pijls-Johannesma M, Lambin P; ROCOCO Consortium. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. J Thorac Oncol 2012;7:165-76. [PMID: 22071782 DOI: 10.1097/JTO.0b013e31823529fc] [Cited by in Crossref: 69] [Cited by in F6Publishing: 27] [Article Influence: 6.9] [Reference Citation Analysis]
279 Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S, Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A, Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM; on behalf of the IMPORT Trials Management Group. A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique. Efficacy and Mechanism Evaluation 2014;1:1-74. [DOI: 10.3310/eme01030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
280 De Ruysscher D, van Baardwijk A, Wanders R, Hendriks LE, Reymen B, van Empt W, Öllers MC, Bootsma G, Pitz C, van Eijsden L, Dingemans AC. Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study. Radiother Oncol 2019;135:141-6. [PMID: 31015160 DOI: 10.1016/j.radonc.2019.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
281 Kazemzadeh N, Modiri A, Samanta S, Yan Y, Bland R, Rozario T, Wibowo H, Iyengar P, Ahn C, Timmerman R, Sawant A. Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR. Int J Radiat Oncol Biol Phys 2018;102:210-8. [PMID: 29891202 DOI: 10.1016/j.ijrobp.2018.04.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
282 Coppes RP, Muijs CT, Faber H, Gross S, Schippers JM, Brandenburg S, Langendijk JA, van Luijk P. Volume-Dependent Expression of In-Field and Out-of-Field Effects in the Proton-Irradiated Rat Lung. International Journal of Radiation Oncology*Biology*Physics 2011;81:262-9. [DOI: 10.1016/j.ijrobp.2011.03.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
283 Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Ueki N, Miyagi K, Norihisa Y, Mizowaki T, Nagata Y. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2012;83:e545-e549. [PMID: 22436782 DOI: 10.1016/j.ijrobp.2012.01.018] [Cited by in Crossref: 119] [Cited by in F6Publishing: 111] [Article Influence: 11.9] [Reference Citation Analysis]
284 Bi J, Qian J, Yang D, Sun L, Lin S, Li Y, Xue X, Nie T, Verma V, Han G. Dosimetric Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors. Front Immunol 2021;12:828858. [PMID: 35095930 DOI: 10.3389/fimmu.2021.828858] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Hoover DA, Reid RH, Wong E, Stitt L, Sabondjian E, Rodrigues GB, Jaswal JK, Yaremko BP. SPECT-based functional lung imaging for the prediction of radiation pneumonitis: a clinical and dosimetric correlation. J Med Imaging Radiat Oncol 2014;58:214-22. [PMID: 24373453 DOI: 10.1111/1754-9485.12145] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
286 Botas P, Grassberger C, Sharp G, Paganetti H. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors. Phys Med Biol 2018;63:035023. [PMID: 29219119 DOI: 10.1088/1361-6560/aaa035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
287 Landoni V, Borzì GR, Strolin S, Bruzzaniti V, Soriani A, D'Alessio D, Ambesi F, Di Grazia AM, Strigari L. Clinical evaluation of X-ray voxel Monte Carlo versus pencil beam-based dose calculation in stereotactic body radiotherapy of lung cancer under normal and deep inspiration breath hold. Technol Cancer Res Treat 2015;14:334-42. [PMID: 25223324 DOI: 10.1177/1533034614547451] [Reference Citation Analysis]
288 Rankine LJ, Wang Z, Kelsey CR, Bier E, Driehuys B, Marks LB, Das SK. Hyperpolarized 129Xe Magnetic Resonance Imaging for Functional Avoidance Treatment Planning in Thoracic Radiation Therapy: A Comparison of Ventilation- and Gas Exchange-Guided Treatment Plans. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)00871-3. [PMID: 34265395 DOI: 10.1016/j.ijrobp.2021.07.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Perkó Z, Bortfeld T, Hong T, Wolfgang J, Unkelbach J. Derivation of mean dose tolerances for new fractionation schemes and treatment modalities. Phys Med Biol 2018;63:035038. [PMID: 29099720 DOI: 10.1088/1361-6560/aa9836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
290 Begosh-Mayne D, Kumar SS, Toffel S, Okunieff P, O'Dell W. The dose-response characteristics of four NTCP models: using a novel CT-based radiomic method to quantify radiation-induced lung density changes. Sci Rep 2020;10:10559. [PMID: 32601297 DOI: 10.1038/s41598-020-67499-0] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
291 De A, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Mascarenhas L, Keens TG, Venkatramani R. Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation: Pulmonary Function Following Lung Irradiation. Pediatr Pulmonol 2015;50:596-603. [DOI: 10.1002/ppul.23034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
292 Kawamura M, Yoshimura M, Nakamura M, Ishihara Y, Mukumoto N, Hirashima H, Iramina H, Hiraoka M, Mizowaki T. Radiotherapy planning techniques to reduce lung irradiation in head and neck cancer patients with mediastinal involvement. Radiol Phys Technol 2020;13:128-35. [PMID: 32157573 DOI: 10.1007/s12194-020-00559-2] [Reference Citation Analysis]
293 Kubo N, Kobayashi D, Iwanaga M, Matsuura M, Higuchi K, Eishima J, Muramatsu H, Okano N, Shioya M, Onishi M, Aoki T, Oike T, Ohno T; Gunma Society for Radiation Oncology (GUSTRO). Radiotherapy Patterns of Care for Locally-advanced Non-small Cell Lung Cancer in the Pre- and Post-durvalumab Era: A Region-wide Survey in a Japanese Prefecture. J Radiat Res 2021:rrab116. [PMID: 34970980 DOI: 10.1093/jrr/rrab116] [Reference Citation Analysis]
294 Heo J, Noh OK, Kim HI, Chun M, Cho O, Park RW, Yoon D, Oh YT. Lung dose and the potential risk of death in postoperative radiation therapy for non-small cell lung cancer: A study using the method of stratified grouping. Radiother Oncol 2018;129:61-7. [PMID: 29681411 DOI: 10.1016/j.radonc.2018.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
295 Suesada MM, Carvalho HA, Albuquerque ALP, Salge JM, Stuart SR, Takagaki TY. Impact of thoracic radiotherapy on respiratory function and exercise capacity in patients with breast cancer. J Bras Pneumol 2018;44:469-76. [PMID: 30726323 DOI: 10.1590/S1806-37562017000000120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
296 Inoue T, Oh RJ, Shiomi H, Masai N, Miura H. Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events. Strahlenther Onkol. 2013;189:285-292. [PMID: 23420546 DOI: 10.1007/s00066-012-0290-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
297 Grassberger C, Dowdell S, Sharp G, Paganetti H. Motion mitigation for lung cancer patients treated with active scanning proton therapy. Med Phys 2015;42:2462-9. [PMID: 25979039 DOI: 10.1118/1.4916662] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
298 Petruzzelli MF, Vasti MP, Tramacere F, D'errico MP, Gianicolo EA, Andreassi MG, Picano E, Portaluri M. The Potential Role of Lung Ultrasound B-Lines for Detection of Lung Radio-Induced Toxicity in Breast Cancer Patients after Radiation Therapy. Echocardiography 2016;33:1374-80. [DOI: 10.1111/echo.13249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
299 Herrmann T, Geyer P, Appold S. The mean lung dose (MLD) : predictive criterion for lung damage? Strahlenther Onkol 2015;191:557-65. [PMID: 25865281 DOI: 10.1007/s00066-015-0833-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
300 MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol 2014;4:116-22. [PMID: 24890352 DOI: 10.1016/j.prro.2013.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
301 Kuperman VY. Effect of radiation protraction in hypofractionated radiotherapy. Med Phys 2018;45:3442-8. [DOI: 10.1002/mp.12936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
302 Spatola C, Militello C, Tocco A, Salamone V, Raffaele L, Migliore M, Pagana A, Milazzotto R, Chillura I, Pergolizzi S, Privitera G. Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma. Future Oncol 2016;12:67-71. [PMID: 27651129 DOI: 10.2217/fon-2016-0330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
303 Kawahara D, Imano N, Nishioka R, Ogawa K, Kimura T, Nakashima T, Iwamoto H, Fujitaka K, Hattori N, Nagata Y. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis. Sci Rep 2021;11:16232. [PMID: 34376721 DOI: 10.1038/s41598-021-95643-x] [Reference Citation Analysis]
304 Mathew L, Vandyk J, Etemad-rezai R, Rodrigues G, Parraga G. Hyperpolarized 3 He pulmonary functional magnetic resonance imaging prior to radiation therapy: Pulmonary MRI prior to radiation therapy. Med Phys 2012;39:4284-90. [DOI: 10.1118/1.4729713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
305 Defraene G, van Elmpt W, Crijns W, Slagmolen P, De Ruysscher D. CT characteristics allow identification of patient-specific susceptibility for radiation-induced lung damage. Radiotherapy and Oncology 2015;117:29-35. [DOI: 10.1016/j.radonc.2015.07.033] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
306 Pöttgen C, Abu Jawad J, Gkika E, Freitag L, Lübcke W, Welter S, Gauler T, Schuler M, Eberhardt WE, Stamatis G, Stuschke M. Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy. J Thorac Dis 2015;7:264-72. [PMID: 25922702 DOI: 10.3978/j.issn.2072-1439.2015.01.59] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Zhao J, Day RM, Jin JY, Quint L, Williams H, Ferguson C, Yan L, King M, Albsheer A, Matuszak M, Kong FS. Thoracic radiation-induced pleural effusion and risk factors in patients with lung cancer. Oncotarget 2017;8:97623-32. [PMID: 29228638 DOI: 10.18632/oncotarget.18824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
308 Wang Y, Chang H, Chang Y, Huang S, Ko H, Chang C, Yeh Y, Jiang J, Lee C, Chi M, Chi K. Serum Amyloid A as a Predictive Marker for Radiation Pneumonitis in Lung Cancer Patients. International Journal of Radiation Oncology*Biology*Physics 2013;85:791-7. [DOI: 10.1016/j.ijrobp.2012.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
309 Cushman TR, Verma V, Rwigema JM. Comparison of proton therapy and intensity modulated photon radiotherapy for locally advanced non-small cell lung cancer: considerations for optimal trial design. J Thorac Dis 2018;10:S988-90. [PMID: 29849214 DOI: 10.21037/jtd.2018.04.59] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
310 Borghetti P, Toraci C, Imbrescia J, Volpi G, Lucchini S, Guerini AE, Magli A, Spiazzi L, Reginelli A, Cappabianca S, Magrini SM, Nardone V. The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy. Ann Nucl Med 2021;35:1174-6. [PMID: 34322785 DOI: 10.1007/s12149-021-01662-z] [Reference Citation Analysis]
311 Shaikh T, Churilla TM, Monpara P, Scott WJ, Cohen SJ, Meyer JE. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer. Pract Radiat Oncol 2016;6:388-94. [PMID: 27025161 DOI: 10.1016/j.prro.2016.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
312 Stana M, Grambozov B, Gaisberger C, Karner J, Ruznic E, Berchtold J, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. Diagnostics 2022;12:1027. [DOI: 10.3390/diagnostics12051027] [Reference Citation Analysis]
313 Sterpin E, Janssens G, Orban de Xivry J, Goossens S, Wanet M, Lee JA, Delor A, Bol V, Vynckier S, Gregoire V, Geets X. Helical tomotherapy for SIB and hypo-fractionated treatments in lung carcinomas: a 4D Monte Carlo treatment planning study. Radiother Oncol 2012;104:173-80. [PMID: 22841518 DOI: 10.1016/j.radonc.2012.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
314 Wang W, Li J, Zhang Y, Shao Q, Xu M, Fan T, Wang J. Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer. Onco Targets Ther 2016;9:4785-91. [PMID: 27536141 DOI: 10.2147/OTT.S104315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
315 Nakamura N. Reexamining the role of tissue inflammation in radiation carcinogenesis: a hypothesis to explain an earlier onset of cancer. Int J Radiat Biol 2021;:1-11. [PMID: 34270352 DOI: 10.1080/09553002.2021.1955998] [Reference Citation Analysis]
316 Anthony GJ, Cunliffe A, Castillo R, Pham N, Guerrero T, Armato SG 3rd, Al-Hallaq HA. Incorporation of pre-therapy 18 F-FDG uptake data with CT texture features into a radiomics model for radiation pneumonitis diagnosis. Med Phys 2017;44:3686-94. [PMID: 28422299 DOI: 10.1002/mp.12282] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
317 Voong KR, Naidoo J. Radiation pneumonitis after definitive chemoradiation and durvalumab for non-small cell lung cancer. Lung Cancer 2020;150:249-51. [DOI: 10.1016/j.lungcan.2020.08.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
318 Fernandez DJ, Sick JT, Fontenot JD. Interplay effects in highly modulated stereotactic body radiation therapy lung cases treated with volumetric modulated arc therapy. J Appl Clin Med Phys 2020;21:58-69. [PMID: 33104297 DOI: 10.1002/acm2.13028] [Reference Citation Analysis]
319 Tanguturi SK, George S, Marcus KJ, Demetri GD, Baldini EH. Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment. Sarcoma 2015;2015:591698. [PMID: 26199562 DOI: 10.1155/2015/591698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
320 Lin C, Huang W, Jen Y, Chen C, Su Y, Chao H, Lin C. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy: VMAT versus IMRT for esophageal cancer. Dis Esophagus 2014;27:585-90. [DOI: 10.1111/dote.12144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
321 Wijsman R, Dankers F, Troost EG, Hoffmann AL, van der Heijden EH, de Geus-oei L, Bussink J. Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT. Radiotherapy and Oncology 2017;122:295-9. [DOI: 10.1016/j.radonc.2016.11.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
322 Hauswald H, Rieken S, Dienemann HC, Thomas M, Kieser M, Debus J, Herfarth K. Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial. BMC Cancer 2015;15:192. [PMID: 25886271 DOI: 10.1186/s12885-015-1163-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
323 Perkins S, Acharya S. Radiation therapy to the developing brain: advanced technology is ready for robust optimization parameters. Neuro Oncol 2021;23:350-1. [PMID: 33560406 DOI: 10.1093/neuonc/noab007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Dinh TK, Fendler W, Chałubińska-Fendler J, Acharya SS, O'Leary C, Deraska PV, D'Andrea AD, Chowdhury D, Kozono D. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer. Radiat Oncol 2016;11:61. [PMID: 27117590 DOI: 10.1186/s13014-016-0636-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
325 Warren S, Partridge M, Carrington R, Hurt C, Crosby T, Hawkins MA. Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2014;90:423-429. [PMID: 25304796 DOI: 10.1016/j.ijrobp.2014.06.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
326 Chalubinska-Fendler J, Fendler W, Spych M, Wyka K, Luniewska-Bury J, Fijuth J. Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancer. Biomed Rep 2016;5:450-4. [PMID: 27699012 DOI: 10.3892/br.2016.739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
327 Sawant A, Yamamoto T, Cai J. Treatment planning based on lung functional avoidance is not ready for clinical deployment. Med Phys 2018;45:2353-6. [PMID: 29570812 DOI: 10.1002/mp.12881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
328 Nalbantov G, Kietselaer B, Vandecasteele K, Oberije C, Berbee M, Troost E, Dingemans AM, van Baardwijk A, Smits K, Dekker A, Bussink J, De Ruysscher D, Lievens Y, Lambin P. Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiother Oncol 2013;109:100-6. [PMID: 24044794 DOI: 10.1016/j.radonc.2013.08.035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
329 Grambozov B, Wolf F, Kaiser J, Wass R, Fastner G, Gaisberger C, Rettenbacher L, Studnicka M, Pirich C, Sedlmayer F, Zehentmayr F. Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer. Thorac Cancer 2020;11:369-78. [PMID: 31855325 DOI: 10.1111/1759-7714.13276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
330 Simeonova A, Abo-madyan Y, El-haddad M, Welzel G, Polednik M, Boggula R, Wenz F, Lohr F. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors. Radiotherapy and Oncology 2012;102:268-73. [DOI: 10.1016/j.radonc.2011.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
331 Antoni D, Natarajan-Ame S, Meyer P, Niederst C, Bourahla K, Noel G. Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease. Radiat Oncol 2013;8:112. [PMID: 23638873 DOI: 10.1186/1748-717X-8-112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 De Rose F, Franceschini D, Reggiori G, Stravato A, Navarria P, Ascolese AM, Tomatis S, Mancosu P, Scorsetti M. Organs at risk in lung SBRT. Phys Med. 2017;44:131-138. [PMID: 28433508 DOI: 10.1016/j.ejmp.2017.04.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
333 Xanthopoulos EP, Handorf E, Simone CB 2nd, Grover S, Fernandes AT, Sharma S, Corradetti MN, Evans TL, Langer CJ, Mitra N, Shah A, Apisarnthanarax S, Lin LL, Rengan R. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. Pract Radiat Oncol 2015;5:e355-63. [PMID: 25649540 DOI: 10.1016/j.prro.2014.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
334 Funke F, Gauler T, Freitag L, Pöttgen C. Using endobronchial valves to reduce irradiation portals in lung cancer: a case report. Pract Radiat Oncol 2014;4:e91-4. [PMID: 24621438 DOI: 10.1016/j.prro.2013.03.002] [Reference Citation Analysis]
335 Bainbridge H, Dunlop A, McQuaid D, Gulliford S, Gunapala R, Ahmed M, Locke I, Nill S, Oelfke U, McDonald F. A Comparison of Isotoxic Dose-escalated Radiotherapy in Lung Cancer with Moderate Deep Inspiration Breath Hold, Mid-ventilation and Internal Target Volume Techniques. Clin Oncol (R Coll Radiol) 2021:S0936-6555(21)00326-5. [PMID: 34503896 DOI: 10.1016/j.clon.2021.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Tsujino K, Hashimoto T, Shimada T, Yoden E, Fujii O, Ota Y, Satouchi M, Negoro S, Adachi S, Soejima T. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer. J Thorac Oncol 2014;9:983-90. [PMID: 24922010 DOI: 10.1097/JTO.0000000000000187] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
337 Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer 2011;117:5250-60. [PMID: 21567385 DOI: 10.1002/cncr.26186] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
338 Cella L, Liuzzi R, D'Avino V, Conson M, Di Biase A, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R. Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury. Acta Oncol 2014;53:613-9. [PMID: 24195693 DOI: 10.3109/0284186X.2013.850739] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
339 Hepel JT, Leonard KL, Safran H, Ng T, Taber A, Khurshid H, Birnbaum A, Wazer DE, DiPetrillo T; Brown University Oncology Research Group. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study. Int J Radiat Oncol Biol Phys 2016;96:1021-7. [PMID: 27745983 DOI: 10.1016/j.ijrobp.2016.08.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
340 Vicente E, Modiri A, Kipritidis J, Hagan A, Yu K, Wibowo H, Yan Y, Owen DR, Matuszak MM, Mohindra P, Timmerman R, Sawant A. Functionally weighted airway sparing (FWAS): a functional avoidance method for preserving post-treatment ventilation in lung radiotherapy. Phys Med Biol 2020;65:165010. [PMID: 32575096 DOI: 10.1088/1361-6560/ab9f5d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
341 Josipovic M, Persson GF, Dueck J, Bangsgaard JP, Westman G, Specht L, Aznar MC. Geometric uncertainties in voluntary deep inspiration breath hold radiotherapy for locally advanced lung cancer. Radiother Oncol 2016;118:510-4. [PMID: 26631647 DOI: 10.1016/j.radonc.2015.11.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
342 Huang TC, Hsiao CY, Chien CR, Liang JA, Shih TC, Zhang GG. IMRT treatment plans and functional planning with functional lung imaging from 4D-CT for thoracic cancer patients. Radiat Oncol 2013;8:3. [PMID: 23281734 DOI: 10.1186/1748-717X-8-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
343 Rassiah P, Esiashvili N, Olch AJ, Hua CH, Ulin K, Molineu A, Marcus K, Gopalakrishnan M, Pillai S, Kovalchuk N, Liu A, Niyazov G, Peñagarícano JA, Cheung F, Olson AC, Wu CC, Malhotra H, MacEwan IJ, Faught J, Breneman JC, Followill DS, FitzGerald TJ, Kalapurakal JA. Practice patterns of pediatric total body irradiation techniques: A Children's Oncology Group survey. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02628-6. [PMID: 34352289 DOI: 10.1016/j.ijrobp.2021.07.1715] [Reference Citation Analysis]
344 Wirsdörfer F, Jendrossek V. Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades. Radiat Oncol 2017;12:142. [PMID: 28836991 DOI: 10.1186/s13014-017-0865-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
345 Oymak E, Yildirim BA, Guler OC, Onal C. Responding to Veiga et al. 'Long term radiological features of radiation-induced lung damage'. Radiother Oncol 2018;129:611-2. [PMID: 30021696 DOI: 10.1016/j.radonc.2018.06.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
346 Lideståhl A, Mondlane G, Gubanski M, Lind PA, Siegbahn A. An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours. Physica Medica 2019;60:120-6. [DOI: 10.1016/j.ejmp.2019.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
347 Lin JC, Tsai JT, Chang CC, Jen YM, Li MH, Liu WH. Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy. Medicine (Baltimore) 2015;94:e750. [PMID: 25929910 DOI: 10.1097/MD.0000000000000750] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
348 Lorentini S, Amichetti M, Spiazzi L, Tonoli S, Magrini SM, Fellin F, Schwarz M. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment. Strahlenther Onkol 2012;188:216-25. [PMID: 22318326 DOI: 10.1007/s00066-011-0038-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
349 Siavashpour Z, Moghani MM, Goharpey N, Mirzai HR, Mohammadi LK, Zayeri F. Correlation between gastric volume and organs at risk dose in adjuvant radiotherapy for left breast cancer. Rep Pract Oncol Radiother 2021;26:367-79. [PMID: 34277090 DOI: 10.5603/RPOR.a2021.0067] [Reference Citation Analysis]
350 Eldh T, Heinzelmann F, Velalakan A, Budach W, Belka C, Jendrossek V. Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent. Strahlenther Onkol 2012;188:274-81. [PMID: 22314577 DOI: 10.1007/s00066-011-0046-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
351 Tucker SL, Li M, Xu T, Gomez D, Yuan X, Yu J, Liu Z, Yin M, Guan X, Wang LE, Wei Q, Mohan R, Vinogradskiy Y, Martel M, Liao Z. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2013;85:251-7. [PMID: 22541966 DOI: 10.1016/j.ijrobp.2012.02.021] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
352 Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol 2021;18:547-57. [PMID: 33911215 DOI: 10.1038/s41571-021-00501-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
353 Jiang W, Song Y, Sun Z, Qiu J, Shi L. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis. Int J Radiat Oncol Biol Phys 2021;110:1161-70. [PMID: 33548340 DOI: 10.1016/j.ijrobp.2021.01.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 van Baardwijk A, Tomé WA, van Elmpt W, Bentzen SM, Reymen B, Wanders R, Houben R, Ollers M, Lambin P, De Ruysscher D. Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review. Radiother Oncol 2012;105:145-9. [PMID: 23068707 DOI: 10.1016/j.radonc.2012.09.008] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
355 Deseyne P, Speleers B, De Neve W, Boute B, Paelinck L, Vakaet V, Van Hulle H, Schoepen M, Stouthandel M, Van Greveling A, Post G, Detand J, Monten C, Depypere H, Veldeman L. Crawl positioning improves set-up precision and patient comfort in prone whole breast irradiation. Sci Rep 2020;10:16376. [PMID: 33009448 DOI: 10.1038/s41598-020-72702-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
356 Trinh H, Pinkham MB, Lehman M, Zarate D, Dauth M, McGrath M, McCaffrey E, Mai GT, Horwood K. Outcomes treating stage III non-small cell lung carcinoma with curative-intent radiotherapy and concurrent carboplatin-paclitaxel chemotherapy. Clin Respir J 2016;10:428-34. [PMID: 25353367 DOI: 10.1111/crj.12233] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
357 Balaji K, Ramasubramanian V. Accelerated hypofractionated radiotherapy for chest wall and nodal irradiation using hybrid techniques. J Radiother Pract. [DOI: 10.1017/s1460396921000601] [Reference Citation Analysis]
358 Komatsu S, Kido M, Asari S, Toyama H, Ajiki T, Demizu Y, Terashima K, Okimoto T, Sasaki R, Fukumoto T. Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis. Surgery 2017;162:1241-9. [PMID: 29031927 DOI: 10.1016/j.surg.2017.08.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
359 Or M, Liu B, Lam J, Vinod S, Xuan W, Yeghiaian-Alvandi R, Hau E. A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer. Sci Rep 2021;11:5939. [PMID: 33723301 DOI: 10.1038/s41598-021-85131-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
360 Lee BM, Chang JS, Kim SY, Keum KC, Suh CO, Kim YB. Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients. Front Oncol 2020;10:124. [PMID: 32117771 DOI: 10.3389/fonc.2020.00124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
361 Lin CT, Shiau AC, Tien HJ, Yeh HP, Shueng PW, Hsieh CH. An attempted substitute study of total skin electron therapy technique by using helical photon tomotherapy with helical irradiation of the total skin treatment: a phantom result. Biomed Res Int 2013;2013:108794. [PMID: 23984313 DOI: 10.1155/2013/108794] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
362 Bowen SR, Saini J, Chapman TR, Miyaoka RS, Kinahan PE, Sandison GA, Wong T, Vesselle HJ, Nyflot MJ, Apisarnthanarax S. Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients. Radiother Oncol. 2015;115:203-210. [PMID: 25934165 DOI: 10.1016/j.radonc.2015.04.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
363 Jethwa KR, Kahila MM, Whitaker TJ, Harmsen WS, Corbin KS, Park SS, Yan ES, Lemaine V, Boughey JC, Mutter RW. Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT). Breast Cancer Res Treat 2017;164:237-44. [DOI: 10.1007/s10549-017-4241-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
364 Kubo N, Saitoh JI, Shimada H, Shirai K, Kawamura H, Ohno T, Nakano T. Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non-small cell lung cancer. J Radiat Res 2016;57:548-54. [PMID: 27242341 DOI: 10.1093/jrr/rrw041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
365 Defraene G, Schuit E, De Ruysscher D. Development and internal validation of a multinomial NTCP model for the severity of acute dyspnea after radiotherapy for lung cancer. Radiother Oncol 2019;136:176-84. [PMID: 31015122 DOI: 10.1016/j.radonc.2019.03.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
366 Mayahara H, Uehara K, Harada A, Kitatani K, Yabuuchi T, Miyazaki S, Ishihara T, Kawaguchi H, Kubota H, Okada H, Ninomaru T, Shindo C, Hata A. Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer. Radiat Oncol 2022;17:7. [PMID: 35033139 DOI: 10.1186/s13014-021-01979-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Massabeau C, Fournier-bidoz N, Wakil G, Castro Pena P, Viard R, Zefkili S, Reyal F, Campana F, Fourquet A, Kirova YM. Implant breast reconstruction followed by radiotherapy: Can helical tomotherapy become a standard irradiation treatment? Medical Dosimetry 2012;37:425-31. [DOI: 10.1016/j.meddos.2012.03.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
368 Tang F, Li R, Xue J, Lan J, Xu H, Liu Y, Zhou L, Lu Y. Azithromycin attenuates acute radiation-induced lung injury in mice. Oncol Lett 2017;14:5211-20. [PMID: 29098024 DOI: 10.3892/ol.2017.6813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
369 Tang C, Mistry H, Bayman N, Chan C, Cobben D, Faivre-Finn C, Harris M, Kennedy J, Pemberton L, Price G, Sheikh H, Woolf D, Coote J, Salem A. Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Radiother Oncol 2021;160:78-81. [PMID: 33901563 DOI: 10.1016/j.radonc.2021.04.014] [Reference Citation Analysis]
370 Majem M, Hernández-Hernández J, Hernando-Trancho F, Rodríguez de Dios N, Sotoca A, Trujillo-Reyes JC, Vollmer I, Delgado-Bolton R, Provencio M. Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer. Clin Transl Oncol 2020;22:21-36. [PMID: 31172444 DOI: 10.1007/s12094-019-02134-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
371 Mehnati P, Ghorbanipoor M, Mohammadzadeh M, Nasiri Motlagh B, Mesbahi A. Predicting the Risk of Radiation Pneumonitis and Pulmonary Function Changes after Breast Cancer Radiotherapy. J Biomed Phys Eng 2021;11:459-64. [PMID: 34458193 DOI: 10.31661/jbpe.v0i0.1079] [Reference Citation Analysis]
372 Cremonesi M, Ferrari M, Botta F, Guerriero F, Garibaldi C, Bodei L, De Cicco C, Grana CM, Pedroli G, Orecchia R. Planning combined treatments of external beam radiation therapy and molecular radiotherapy. Cancer Biother Radiopharm 2014;29:227-37. [PMID: 25006794 DOI: 10.1089/cbr.2014.1607] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
373 Flejmer AM, Chehrazi B, Josefsson D, Toma-dasu I, Dasu A. Impact of physiological breathing motion for breast cancer radiotherapy with proton beam scanning – An in silico study. Physica Medica 2017;39:88-94. [DOI: 10.1016/j.ejmp.2017.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
374 Zhang R, Heins D, Sanders M, Guo B, Hogstrom K. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy. Med Phys 2018;45:2912-24. [PMID: 29749075 DOI: 10.1002/mp.12958] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
375 Sharifi H, van Elmpt W, Oberije C, Nalbantov G, Das M, Öllers M, Lambin P, Dingmans AM, De Ruysscher D. Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab. Acta Oncol 2016;55:156-62. [PMID: 26399389 DOI: 10.3109/0284186X.2015.1080856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
376 Wu Q, Xu F. Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report. World J Clin Cases 2021; 9(31): 9535-9541 [PMID: 34877287 DOI: 10.12998/wjcc.v9.i31.9535] [Reference Citation Analysis]
377 Bertelsen A, Hansen O, Brink C. Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - a planning study. Acta Oncol 2012;51:752-8. [PMID: 22248064 DOI: 10.3109/0284186X.2011.648341] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
378 Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, Bradley JD, Kim TH, Ramella S, Marks LB. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;85:444-450. [PMID: 22682812 DOI: 10.1016/j.ijrobp.2012.04.043] [Cited by in Crossref: 325] [Cited by in F6Publishing: 313] [Article Influence: 32.5] [Reference Citation Analysis]
379 Couñago F, de la Pinta C, Gonzalo S, Fernández C, Almendros P, Calvo P, Taboada B, Gómez-Caamaño A, Guerra JLL, Chust M, González Ferreira JA, Álvarez González A, Casas F. GOECP/SEOR radiotherapy guidelines for small-cell lung cancer. World J Clin Oncol 2021; 12(3): 115-143 [PMID: 33767969 DOI: 10.5306/wjco.v12.i3.115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
380 Corbin KS, Mutter RW. Proton therapy for breast cancer: progress & pitfalls. Breast Cancer Management 2018;7:BMT06. [DOI: 10.2217/bmt-2018-0001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
381 Chen H, Huang Y, Wang H, Shao Y, Yue NJ, Gu H, Duan Y, Feng A, Xu Z. Dosimetric comparison and biological evaluation of fixed-jaw intensity-modulated radiation therapy for T-shaped esophageal cancer. Radiat Oncol 2021;16:158. [PMID: 34412656 DOI: 10.1186/s13014-021-01882-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
382 Luo Y, McShan DL, Matuszak MM, Ray D, Lawrence TS, Jolly S, Kong FM, Ten Haken RK, El Naqa I. A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy. Med Phys 2018. [PMID: 29862533 DOI: 10.1002/mp.13029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
383 Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee. Int J Radiat Oncol Biol Phys 2021;111:337-59. [PMID: 34048815 DOI: 10.1016/j.ijrobp.2021.05.110] [Reference Citation Analysis]
384 Flejmer AM, Edvardsson A, Dohlmar F, Josefsson D, Nilsson M, Witt Nyström P, Dasu A. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy. Acta Oncol 2016;55:577-83. [PMID: 27027913 DOI: 10.3109/0284186X.2015.1120883] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
385 Robertson SP, Quon H, Kiess AP, Moore JA, Yang W, Cheng Z, Afonso S, Allen M, Richardson M, Choflet A, Sharabi A, Mcnutt TR. A data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patients: A data-mining algorithm for dose-outcome analysis. Med Phys 2015;42:4329-37. [DOI: 10.1118/1.4922686] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
386 McDonald F, Popat S. Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC. J Thorac Dis 2014;6:356-68. [PMID: 24688780 DOI: 10.3978/j.issn.2072-1439.2013.12.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
387 Vinogradskiy Y, Rusthoven CG, Schubert L, Jones B, Faught A, Castillo R, Castillo E, Gaspar LE, Kwak J, Waxweiler T, Dougherty M, Gao D, Stevens C, Miften M, Kavanagh B, Guerrero T, Grills I. Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys 2018;102:1357-65. [PMID: 30353873 DOI: 10.1016/j.ijrobp.2018.07.186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
388 Sun T, Lin X, Tong Y, Liu X, Pan L, Tao C, Duan J, Yin Y. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy. Front Oncol 2019;9:1456. [PMID: 31998635 DOI: 10.3389/fonc.2019.01456] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
389 Glatzer M, Elicin O, Ramella S, Nestle U, Putora PM. Radio(chemo)therapy in locally advanced nonsmall cell lung cancer. Eur Respir Rev. 2016;25:65-70. [PMID: 26929423 DOI: 10.1183/16000617.0053-2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
390 DeCesaris CM, Pollock A, Zhang B, Poirier Y, Kowalski E, Paulosky K, Mishra MV, Nichols E. Assessing the Need for Adjusted Organ-at-Risk Planning Goals for Patients Undergoing Adjuvant Radiation Therapy for Locally Advanced Breast Cancer with Proton Radiation. Pract Radiat Oncol 2021;11:108-18. [PMID: 33109494 DOI: 10.1016/j.prro.2020.09.003] [Reference Citation Analysis]
391 Boer CG, Fjellanger K, Sandvik IM, Ugland M, Engeseth GM, Hysing LB. Substantial Sparing of Organs at Risk with Modern Proton Therapy in Lung Cancer, but Altered Breathing Patterns Can Jeopardize Target Coverage. Cancers (Basel) 2022;14:1365. [PMID: 35326516 DOI: 10.3390/cancers14061365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 Cunliffe AR, Contee C, Armato SG 3rd, White B, Justusson J, Malik R, Al-Hallaq HA. Effect of deformable registration on the dose calculated in radiation therapy planning CT scans of lung cancer patients. Med Phys 2015;42:391-9. [PMID: 25563279 DOI: 10.1118/1.4903267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
393 Xia W, Han F, Chen J, Miao J, Dai J. Personalized setting of plan parameters using feasibility dose volume histogram for auto-planning in Pinnacle system. J Appl Clin Med Phys 2020;21:119-27. [PMID: 32363757 DOI: 10.1002/acm2.12897] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
394 Osman SO, Hol S, Poortmans PM, Essers M. Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation. Radiother Oncol 2014;112:17-22. [PMID: 24825176 DOI: 10.1016/j.radonc.2014.04.004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 10.5] [Reference Citation Analysis]
395 Yorke ED, Jackson A, Kuo LC, Ojo A, Panchoo K, Adusumilli P, Zauderer MG, Rusch VW, Shepherd A, Rimner A. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys 2017;99:61-9. [PMID: 28816162 DOI: 10.1016/j.ijrobp.2017.04.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
396 Collie D, Wright SH, Del-Pozo J, Kay E, Schwarz T, Parys M, Lawrence J. Regional and organ-level responses to local lung irradiation in sheep. Sci Rep 2021;11:9553. [PMID: 33953285 DOI: 10.1038/s41598-021-88863-8] [Reference Citation Analysis]
397 Sardaro A, McDonald F, Bardoscia L, Lavrenkov K, Singh S, Ashley S, Traish D, Ferrari C, Meattini I, Asabella AN, Brada M. Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study. Front Oncol 2020;10:594590. [PMID: 33425746 DOI: 10.3389/fonc.2020.594590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
398 Verbanck S, Hanon S, Schuermans D, Van Parijs H, Vinh-Hung V, Miedema G, Verellen D, Storme G, Fontaine C, Lamote J, De Ridder M, Vincken W. Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up. Int J Radiat Oncol Biol Phys 2016;95:937-45. [PMID: 27302510 DOI: 10.1016/j.ijrobp.2016.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
399 Kepka L, Bujko K, Orlowski TM, Jagiello R, Salata A, Matecka-nowak M, Janowski H, Rogowska D. Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy. Radiotherapy and Oncology 2011;98:238-43. [DOI: 10.1016/j.radonc.2010.09.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
400 Sharfo AWM, Stieler F, Kupfer O, Heijmen BJM, Dirkx MLP, Breedveld S, Wenz F, Lohr F, Boda-Heggemann J, Buergy D. Automated VMAT planning for postoperative adjuvant treatment of advanced gastric cancer. Radiat Oncol 2018;13:74. [PMID: 29685166 DOI: 10.1186/s13014-018-1032-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
401 Harrabi SB, Koerber SA, Adeberg S, Katayama S, Herfarth K, Debus J, Sterzing F. Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy. Rep Pract Oncol Radiother 2017;22:402-7. [PMID: 28831280 DOI: 10.1016/j.rpor.2017.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
402 Pepek JM, Willett CG, Czito BG. Technical considerations in radiation therapy for gastroesophageal junction cancer. Semin Radiat Oncol. 2013;23:51-59. [PMID: 23207047 DOI: 10.1016/j.semradonc.2012.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
403 Francis SR, Anker CJ, Wang B, Williams GV, Cox K, Adler DG, Shrieve DC, Salter BJ. Self-expanding stent effects on radiation dosimetry in esophageal cancer. J Appl Clin Med Phys 2013;14:4218. [PMID: 23835387 DOI: 10.1120/jacmp.v14i4.4218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
404 Kim T, Pollock S, Lee D, O'Brien R, Keall P. Audiovisual biofeedback improves diaphragm motion reproducibility in MRI. Med Phys 2012;39:6921-8. [PMID: 23127085 DOI: 10.1118/1.4761866] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
405 Doi H, Nakamatsu K, Nishimura Y. Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review. Int J Clin Oncol 2019;24:899-909. [PMID: 30937620 DOI: 10.1007/s10147-019-01432-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
406 Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, De Cicco C, Bonomo G, Orsi F, Bodei L, Di Dia A, Grana CM, Orecchia R. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol 2014;4:210. [PMID: 25191640 DOI: 10.3389/fonc.2014.00210] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 10.5] [Reference Citation Analysis]
407 Tang Y, Liu B, Li J, Wu H, Yang J, Zhou X, Yi M, Li Q, Yu S, Yuan X. Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy. Cancer Med 2016;5:24-32. [PMID: 26645682 DOI: 10.1002/cam4.564] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
408 Chen MQ, Chen C, Lu HJ, Xu BH. The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma. J Thorac Dis. 2015;7:1749-1755. [PMID: 26623097 DOI: 10.3978/j.issn.2072-1439.2015.10.23] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
409 Borca VC, Franco P, Catuzzo P, Migliaccio F, Zenone F, Aimonetto S, Peruzzo A, Pasquino M, Russo G, La Porta MR, Cante D, Sciacero P, Girelli G, Ricardi U, Tofani S. Does TomoDirect 3DCRT represent a suitable option for post-operative whole breast irradiation? A hypothesis-generating pilot study. Radiat Oncol 2012;7:211. [PMID: 23241224 DOI: 10.1186/1748-717X-7-211] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
410 Rohrer Bley C, Meier VS, Besserer J, Schneider U. Intensity‐modulated radiation therapy dose prescription and reporting: Sum and substance of the International Commission on Radiation Units and Measurements Report 83 for veterinary medicine. Vet Radiol Ultrasound 2019;60:255-64. [DOI: 10.1111/vru.12722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
411 Farr KP, Kramer S, Khalil AA, Morsing A, Grau C. Role of perfusion SPECT in prediction and measurement of pulmonary complications after radiotherapy for lung cancer. Eur J Nucl Med Mol Imaging 2015;42:1315-24. [DOI: 10.1007/s00259-015-3052-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
412 Wang L, Li C, Meng X, Li C, Sun X, Shang D, Pang L, Li Y, Lu J, Yu J. Dosimetric and Radiobiological Comparison of External Beam Radiotherapy Using Simultaneous Integrated Boost Technique for Esophageal Cancer in Different Location. Front Oncol 2019;9:674. [PMID: 31404144 DOI: 10.3389/fonc.2019.00674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
413 Wu CT, Motegi A, Motegi K, Hotta K, Kohno R, Tachibana H, Kumagai M, Nakamura N, Hojo H, Niho S, Goto K, Akimoto T. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer. Jpn J Clin Oncol 2016;46:1008-14. [PMID: 27511988 DOI: 10.1093/jjco/hyw108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
414 Wang J, Hu W, Yang Z, Chen X, Wu Z, Yu X, Guo X, Lu S, Li K, Yu G. Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients? Radiat Oncol 2017;12:85. [PMID: 28532508 DOI: 10.1186/s13014-017-0822-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
415 Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, Bradley JD. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51-60. [PMID: 20874426 DOI: 10.3109/0284186X.2010.521192] [Cited by in Crossref: 101] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
416 Stinauer MA, Kavanagh BD, Mitchell JD. Presumed early-stage lung cancer treated with stereotactic body radiation therapy in a medically inoperable patient with multiple connective tissue disorders. Practical Radiation Oncology 2012;2:e133-6. [DOI: 10.1016/j.prro.2011.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
417 Al Feghali KA, Wu QC, Devpura S, Liu C, Ghanem AI, Wen NW, Ajlouni M, Simoff MJ, Movsas B, Chetty IJ. Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer. Clin Transl Radiat Oncol 2020;22:1-8. [PMID: 32140574 DOI: 10.1016/j.ctro.2020.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
418 Hörner-Rieber J, Dern J, Bernhardt D, König L, Adeberg S, Verma V, Paul A, Kappes J, Hoffmann H, Debus J, Heussel CP, Rieken S. Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer-Experiences from a Single Institution. Front Oncol 2017;7:215. [PMID: 28975083 DOI: 10.3389/fonc.2017.00215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
419 Waxweiler T, Schubert L, Diot Q, Faught A, Stuhr K, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M, Vinogradskiy Y. A complete 4DCT-ventilation functional avoidance virtual trial: Developing strategies for prospective clinical trials. J Appl Clin Med Phys 2017;18:144-52. [PMID: 28436107 DOI: 10.1002/acm2.12086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
420 Fleckenstein J, Kremp K, Kremp S, Palm J, Rübe C. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning. Strahlenther Onkol 2016;192:75-82. [PMID: 26438071 DOI: 10.1007/s00066-015-0900-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
421 Schytte T, Nielsen TB, Brink C, Hansen O. Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer. Acta Oncol 2014;53:336-41. [PMID: 24369735 DOI: 10.3109/0284186X.2013.868035] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
422 Tonison JJ, Fischer SG, Viehrig M, Welz S, Boeke S, Zwirner K, Klumpp B, Braun LH, Zips D, Gani C. Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review. Sci Rep 2019;9:2255. [PMID: 30783157 DOI: 10.1038/s41598-018-38414-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
423 Wurstbauer K, Zehentmayr F, Deutschmann H, Dagn K, Exeli AK, Kopp P, Porsch P, Maurer B, Studnicka M, Sedlmayer F. DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints. Strahlenther Onkol 2017;193:315-23. [PMID: 28116446 DOI: 10.1007/s00066-016-1095-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
424 De Ruysscher D, Faivre-finn C, Nestle U, Hurkmans CW, Le Péchoux C, Price A, Senan S. European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer. JCO 2010;28:5301-10. [DOI: 10.1200/jco.2010.30.3271] [Cited by in Crossref: 181] [Cited by in F6Publishing: 59] [Article Influence: 15.1] [Reference Citation Analysis]
425 Dreyfuss AD, Jahangiri P, Simone CB 2nd, Alavi A. Evolving Role of Novel Quantitative PET Techniques to Detect Radiation-Induced Complications. PET Clin 2020;15:89-100. [PMID: 31735305 DOI: 10.1016/j.cpet.2019.08.003] [Reference Citation Analysis]
426 Edvardsson A, Nilsson MP, Amptoulach S, Ceberg S. Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm. Radiat Oncol 2015;10:84. [PMID: 25884950 DOI: 10.1186/s13014-015-0375-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
427 Scaife JE, Barnett GC, Noble DJ, Jena R, Thomas SJ, West CM, Burnet NG. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015;88:20150172. [PMID: 26084351 DOI: 10.1259/bjr.20150172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
428 West NS, Parkes MJ, Snowden C, Prentis J, McKenna J, Iqbal MS, Cashmore J, Walker C. Mitigating Respiratory Motion in Radiation Therapy: Rapid, Shallow, Non-invasive Mechanical Ventilation for Internal Thoracic Targets. Int J Radiat Oncol Biol Phys 2019;103:1004-10. [PMID: 30496883 DOI: 10.1016/j.ijrobp.2018.11.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
429 Dauer LT, Yorke E, Williamson M, Gao Y, Dauer ZL, Miller DL, Vañó E. Radiotherapeutic implications of the updated ICRP thresholds for tissue reactions related to cataracts and circulatory diseases. Ann ICRP 2018;47:196-213. [PMID: 29741403 DOI: 10.1177/0146645318759622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
430 Fogliata A, De Rose F, Franceschini D, Stravato A, Seppälä J, Scorsetti M, Cozzi L. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. International Journal of Radiation Oncology*Biology*Physics 2018;100:785-93. [DOI: 10.1016/j.ijrobp.2017.10.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
431 Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR Jr, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS, Mohan R. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 2018;36:1813-22. [PMID: 29293386 DOI: 10.1200/JCO.2017.74.0720] [Cited by in Crossref: 116] [Cited by in F6Publishing: 73] [Article Influence: 29.0] [Reference Citation Analysis]
432 Steel H, Pollock S, Lee D, Keall P, Kim T. The internal–external respiratory motion correlation is unaffected by audiovisual biofeedback. Australas Phys Eng Sci Med 2014;37:97-102. [DOI: 10.1007/s13246-014-0247-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
433 Cheng HW, Chang CC, Shiau AC, Wang MH, Tsai JT. Dosimetric comparison of helical tomotherapy, volumetric-modulated arc therapy, intensity-modulated radiotherapy, and field-in-field technique for synchronous bilateral breast cancer. Med Dosim 2020;45:271-7. [PMID: 32122694 DOI: 10.1016/j.meddos.2020.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
434 Budach W, Bölke E, Matuschek C. Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials. Breast Care (Basel) 2015;10:240-5. [PMID: 26600759 DOI: 10.1159/000439007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
435 Faggiano E, Cattaneo GM, Ciavarro C, Dell'Oca I, Persano D, Calandrino R, Rizzo G. Validation of an elastic registration technique to estimate anatomical lung modification in non-small-cell lung cancer tomotherapy. Radiat Oncol 2011;6:31. [PMID: 21470411 DOI: 10.1186/1748-717X-6-31] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
436 Kuo AH, Ancukiewicz M, Kozak KR, Yock TI, Padera TP. Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation. Radiat Oncol 2015;10:5. [PMID: 25573181 DOI: 10.1186/s13014-014-0324-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
437 Yirmibesoglu E, Higginson DS, Fayda M, Rivera MP, Halle J, Rosenman J, Xie L, Marks LB. Challenges scoring radiation pneumonitis in patients irradiated for lung cancer. Lung Cancer 2012;76:350-3. [PMID: 22230037 DOI: 10.1016/j.lungcan.2011.11.025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
438 Niska JR, Schild SE, Rule WG, Daniels TB, Jett JR. Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease. Clin Lung Cancer 2018;19:e417-20. [PMID: 29526532 DOI: 10.1016/j.cllc.2018.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
439 Ebert N, Baumann M, Troost EG. Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning? Radiother Oncol 2015;117:1-3. [PMID: 26372342 DOI: 10.1016/j.radonc.2015.09.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
440 Saha A, Beasley M, Hatton N, Dickinson P, Franks K, Clarke K, Jain P, Teo M, Murray P, Lilley J. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients. Radiother Oncol 2021;156:153-9. [PMID: 33333139 DOI: 10.1016/j.radonc.2020.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
441 van der Veen SJ, Faber H, Ghobadi G, Brandenburg S, Langendijk JA, Coppes RP, van Luijk P. Decreasing Irradiated Rat Lung Volume Changes Dose-Limiting Toxicity From Early to Late Effects. Int J Radiat Oncol Biol Phys 2016;94:163-71. [PMID: 26700710 DOI: 10.1016/j.ijrobp.2015.09.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
442 Pan WY, Bian C, Zou GL, Zhang CY, Hai P, Zhao R, Wang YY. Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy. Oncotarget 2017;8:81387-93. [PMID: 29113398 DOI: 10.18632/oncotarget.19032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
443 Lee S, Stroian G, Kopek N, Albahhar M, Seuntjens J, Naqa IE. Analytical modelling of regional radiotherapy dose response of lung. Phys Med Biol 2012;57:3309-21. [DOI: 10.1088/0031-9155/57/11/3309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
444 Mueller M, Booth J, Briggs A, Jayamanne D, Panettieri V, Senthi S, Shieh C, Keall P. MArkerless image Guidance using Intrafraction Kilovoltage x-ray imaging (MAGIK): study protocol for a phase I interventional study for lung cancer radiotherapy. BMJ Open 2022;12:e057135. [DOI: 10.1136/bmjopen-2021-057135] [Reference Citation Analysis]
445 Niezink AGH, de Jong RA, Muijs CT, Langendijk JA, Widder J. Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters. Oncologist 2017;22:1257-64. [PMID: 28550029 DOI: 10.1634/theoncologist.2016-0324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
446 Schültke E, Balosso J, Breslin T, Cavaletti G, Djonov V, Esteve F, Grotzer M, Hildebrandt G, Valdman A, Laissue J. Microbeam radiation therapy - grid therapy and beyond: a clinical perspective. Br J Radiol 2017;90:20170073. [PMID: 28749174 DOI: 10.1259/bjr.20170073] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
447 Uchida Y, Tsugawa T, Tanaka-Mizuno S, Noma K, Aoki K, Shigemori W, Nakagawa H, Kinose D, Yamaguchi M, Osawa M, Ogawa E, Nakano Y. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis. Radiat Oncol 2017;12:160. [PMID: 28969651 DOI: 10.1186/s13014-017-0891-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
448 Guo T, Zou L, Ni J, Zhou Y, Ye L, Yang X, Zhu Z. Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury. Front Immunol 2020;11:1769. [PMID: 32849634 DOI: 10.3389/fimmu.2020.01769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
449 Marc L, Fabiano S, Wahl N, Linsenmeier C, Lomax AJ, Unkelbach J. Combined proton-photon treatment for breast cancer. Phys Med Biol 2021;66. [PMID: 34736246 DOI: 10.1088/1361-6560/ac36a3] [Reference Citation Analysis]
450 Ong CL, Palma D, Verbakel WF, Slotman BJ, Senan S. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity. Radiother Oncol. 2010;97:431-436. [PMID: 20971523 DOI: 10.1016/j.radonc.2010.10.003] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 8.8] [Reference Citation Analysis]
451 Caudrelier JM, Meng J, Esche B, Grimard L, Ruddy T, Amjadi K. IMRT sparing of normal tissues in locoregional treatment of breast cancer. Radiat Oncol 2014;9:161. [PMID: 25052720 DOI: 10.1186/1748-717X-9-161] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
452 Saynak M, Higginson DS, Morris DE, Marks LB. Current Status of Postoperative Radiation for Non–Small-Cell Lung Cancer. Seminars in Radiation Oncology 2010;20:192-200. [DOI: 10.1016/j.semradonc.2010.01.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
453 Schröder C, Stiefel I, Tanadini-Lang S, Pytko I, Vu E, Guckenberger M, Andratschke N. Re-irradiation in the thorax - An analysis of efficacy and safety based on accumulated EQD2 doses. Radiother Oncol 2020;152:56-62. [PMID: 32717358 DOI: 10.1016/j.radonc.2020.07.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
454 Domenicano I, Ventz S, Cellamare M, Mak RH, Trippa L. Bayesian uncertainty‐directed dose finding designs. J R Stat Soc C 2019;68:1393-410. [DOI: 10.1111/rssc.12355] [Reference Citation Analysis]
455 Cooper SL, Russo JK, Chin S. Definitive chemoradiotherapy for esophageal carcinoma. Surg Clin North Am. 2012;92:1213-1248. [PMID: 23026279 DOI: 10.1016/j.suc.2012.07.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
456 Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012;51:975-83. [PMID: 22950387 DOI: 10.3109/0284186X.2012.718093] [Cited by in Crossref: 138] [Cited by in F6Publishing: 82] [Article Influence: 13.8] [Reference Citation Analysis]
457 Møller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Drøgemüller Lund M, Hansen O, Schytte T, Khalil AA, Knap MM, Nyhus CH, Ottosson W, Sibolt P, Borissova S, Josipovic M, Persson G, Appelt AL. Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study. Radiotherapy and Oncology 2017;124:311-7. [DOI: 10.1016/j.radonc.2017.06.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
458 Cho WK, Oh D, Kim HK, Ahn YC, Noh JM, Shim YM, Zo JI, Choi YS, Sun J, Lee S, Ahn M, Park K, Nam H. Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery. Radiotherapy and Oncology 2019;133:87-92. [DOI: 10.1016/j.radonc.2019.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
459 Del Castillo R, Martinez D, Sarria GJ, Pinillos L, Garcia B, Castillo L, Carhuactocto A, Giordano FA, Sarria GR. Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review. Strahlenther Onkol 2020;196:1086-93. [PMID: 32816059 DOI: 10.1007/s00066-020-01675-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
460 Merrow CE, Wang IZ, Podgorsak MB. A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer. J Appl Clin Med Phys 2012;14:4110. [PMID: 23318374 DOI: 10.1120/jacmp.v14i1.4110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
461 Venkatramani R, Olch AJ, Mascarenhas L, Yoon S, Suterwala B, Mehta B, Wong K. Correlation of long-term pulmonary injury with radiation dose distribution in childhood cancer survivors. Pract Radiat Oncol 2012;2:237-40. [PMID: 24674127 DOI: 10.1016/j.prro.2011.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
462 Boekhoff M, Defize I, Borggreve A, van Hillegersberg R, Kotte A, Lagendijk J, van Lier A, Ruurda J, Takahashi N, Mook S, Meijer G. An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients. Radiother Oncol 2021;162:76-84. [PMID: 34237345 DOI: 10.1016/j.radonc.2021.06.038] [Reference Citation Analysis]
463 Mullins J, Renaud MA, Serban M, Seuntjens J. Simultaneous trajectory generation and volumetric modulated arc therapy optimization. Med Phys 2020;47:3078-90. [PMID: 32215936 DOI: 10.1002/mp.14155] [Reference Citation Analysis]
464 Chen Q, Carlton D, Howard TJ, Izumi T, Rong Y. Technical Note: Vendor miscalibration of preclinical orthovoltage irradiator identified through independent output check. Med Phys 2021;48:881-9. [PMID: 33283893 DOI: 10.1002/mp.14642] [Reference Citation Analysis]
465 Nitsche M, Temme N, Förster M, Reible M, Hermann RM. Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study. Strahlenther Onkol 2014;190:715-21. [PMID: 24838410 DOI: 10.1007/s00066-014-0681-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
466 Visser S, Neh H, Oraboni Ribeiro C, Korevaar EW, Meijers A, Poppe B, Sijtsema NM, Both S, Langendijk JA, Muijs CT, Knopf AC. Assessment of a diaphragm override strategy for robustly optimized proton therapy planning for esophageal cancer patients. Med Phys 2021. [PMID: 34289123 DOI: 10.1002/mp.15114] [Reference Citation Analysis]
467 Kornerup JS, Brodin NP, Björk-Eriksson T, Birk Christensen C, Kiil-Berthelsen A, Aznar MC, Hollensen C, Markova E, Munck Af Rosenschöld P. PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy. Br J Radiol 2015;88:20140586. [PMID: 25494657 DOI: 10.1259/bjr.20140586] [Reference Citation Analysis]
468 Deraska PV, O'Leary C, Reavis HD, Labe S, Dinh TK, Lazaro JB, Sweeney C, D'Andrea AD, Kozono D. NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair. Cell Death Discov 2018;4:10. [PMID: 29531807 DOI: 10.1038/s41420-017-0008-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
469 Khalil AA, Hau E, Gebski V, Grau C, Gee H, Nyeng TB, West K, Kramer S, Farlow D, Knap M, Møller DS, Hoffmann L, Farr KP. Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial. BMC Cancer 2021;21:940. [PMID: 34418994 DOI: 10.1186/s12885-021-08663-1] [Reference Citation Analysis]
470 Hoffmann AL, Nahum AE. Fractionation in normal tissues: the (α/β) eff concept can account for dose heterogeneity and volume effects. Phys Med Biol 2013;58:6897-914. [DOI: 10.1088/0031-9155/58/19/6897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
471 Jensen KR, Brink C, Hansen O, Bernchou U. Ventilation measured on clinical 4D-CBCT: Increased ventilation accuracy through improved image quality. Radiotherapy and Oncology 2017;125:459-63. [DOI: 10.1016/j.radonc.2017.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
472 Tighe RM, Heck K, Soderblom E, Zhou S, Birukova A, Young K, Rouse D, Vidas J, Komforti MK, Toomey CB, Cuttitta F, Sunday ME. Immediate Release of Gastrin-Releasing Peptide Mediates Delayed Radiation-Induced Pulmonary Fibrosis. Am J Pathol 2019;189:1029-40. [PMID: 30898588 DOI: 10.1016/j.ajpath.2019.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
473 Yamaguchi S, Ohguri T, Matsuki Y, Yahara K, Oki H, Imada H, Narisada H, Korogi Y. Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis. Int J Clin Oncol 2015;20:45-52. [DOI: 10.1007/s10147-014-0679-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
474 Balaji Subramanian S, Balaji K, Thirunavukarasu M, Premkumar S. Bilateral Breast Irradiation Using Hybrid Volumetric Modulated Arc Therapy (h-VMAT) Technique: A Planning Case Report. Cureus 2016;8:e914. [PMID: 28083458 DOI: 10.7759/cureus.914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
475 Kashihara T, Nakayama Y, Ito K, Kubo Y, Okuma K, Shima S, Nakamura S, Takahashi K, Inaba K, Murakami N, Igaki H, Ohe Y, Kusumoto M, Itami J. Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer. Adv Radiat Oncol 2021;6:100606. [PMID: 33665489 DOI: 10.1016/j.adro.2020.10.019] [Reference Citation Analysis]
476 Kindts I, Defraene G, Laenen A, Petillion S, Van Limbergen E, Depuydt T, Weltens C. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy. Acta Oncol 2018;57:916-23. [PMID: 29652212 DOI: 10.1080/0284186X.2018.1461926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
477 Unkelbach J, Craft D, Salari E, Ramakrishnan J, Bortfeld T. The dependence of optimal fractionation schemes on the spatial dose distribution. Phys Med Biol 2013;58:159-67. [PMID: 23221166 DOI: 10.1088/0031-9155/58/1/159] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
478 Ramasubramanian V, Balaji K, Balaji Subramanian S, Sathiya K, Thirunavukarasu M, Radha CA. Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs. Radiol Med 2019;124:546-54. [PMID: 30701385 DOI: 10.1007/s11547-019-00994-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
479 Peng S, Song R, Lin Q, Zhang Y, Yang Y, Luo M, Zhong Z, Xu X, Lu L, Yao S, Zhang F. A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy. Adv Sci (Weinh) 2021;8:2002567. [PMID: 33854878 DOI: 10.1002/advs.202002567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
480 Hedin E, Bäck A, Chakarova R. Impact of lung density on the lung dose estimation for radiotherapy of breast cancer. Physics and Imaging in Radiation Oncology 2017;3:5-10. [DOI: 10.1016/j.phro.2017.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
481 Jackson IL, Zhang Y, Bentzen SM, Hu J, Zhang A, Vujaskovic Z. Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse. Sci Rep 2016;6:36579. [PMID: 27845360 DOI: 10.1038/srep36579] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
482 Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys 2012;84:238-43. [PMID: 22300564 DOI: 10.1016/j.ijrobp.2011.11.013] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
483 Peters M, Taylor B, Turner E. An Evidence-Based Review of Total Body Irradiation. J Med Imaging Radiat Sci 2015;46:442-9. [PMID: 31052126 DOI: 10.1016/j.jmir.2015.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
484 Duzenli C, Koulis T, Menna T, Carpentier E, Arora T, Coope R, Gill B, Lim P, Aquino-Parsons C, Nichol A, Singer J, Ingledew PA, Grahame S, Chan EK. Reduction in Doses to Organs at Risk and Normal Tissue During Breast Radiation Therapy With a Carbon-Fiber Adjustable Reusable Accessory. Pract Radiat Oncol 2021:S1879-8500(21)00201-0. [PMID: 34303034 DOI: 10.1016/j.prro.2021.06.012] [Reference Citation Analysis]
485 Bree ID, van Hinsberg MG, van Veelen LR. High-dose radiotherapy in inoperable nonsmall cell lung cancer: Comparison of volumetric modulated arc therapy, dynamic IMRT and 3D conformal radiotherapy. Medical Dosimetry 2012;37:353-7. [DOI: 10.1016/j.meddos.2011.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
486 Omballi M, Fernandez-Bussy S, Patel PP, Jantz MA, Becnel D, Patel NM, Mehta HJ. Surveillance Imaging After Curative Intent Therapy for Lung Cancer. Semin Roentgenol 2020;55:60-9. [PMID: 31964482 DOI: 10.1053/j.ro.2019.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
487 Bertelsen A, Schytte T, Bentzen SM, Hansen O, Nielsen M, Brink C. Radiation dose response of normal lung assessed by Cone Beam CT – A potential tool for biologically adaptive radiation therapy. Radiotherapy and Oncology 2011;100:351-5. [DOI: 10.1016/j.radonc.2011.08.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
488 Ghobadi G, Wiegman EM, Langendijk JA, Widder J, Coppes RP, van Luijk P. A new CT-based method to quantify radiation-induced lung damage in patients. Radiotherapy and Oncology 2015;117:4-8. [DOI: 10.1016/j.radonc.2015.07.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
489 Mihaylov IB, Moros EG. Dose-mass inverse optimization for minimally moving thoracic lesions. Phys Med Biol 2015;60:3927-37. [PMID: 25909516 DOI: 10.1088/0031-9155/60/10/3927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
490 Zhou Y, Xiang X, Xiong J, Gong C. Comprehensive Comparison of Progressive Optimization Algorithm Based Automatic Plan and Manually Planned Treatment Technique for Cervical-Thoracic Esophageal Cancers. Technol Cancer Res Treat 2020;19:1533033820973283. [PMID: 33176589 DOI: 10.1177/1533033820973283] [Reference Citation Analysis]
491 Jin J, Kong F. Personalized Radiation Therapy (PRT) for Lung Cancer. In: Ahmad A, Gadgeel SM, editors. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Cham: Springer International Publishing; 2016. pp. 175-202. [DOI: 10.1007/978-3-319-24932-2_10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
492 Boyce-Fappiano D, Nguyen QN, Chapman BV, Allen PK, Gjyshi O, Pezzi TA, De B, Gomez D, Lin SH, Chang JY, Liao Z, Lee P, Gandhi SJ. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer. Clin Lung Cancer 2021:S1525-7304(21)00025-5. [PMID: 33707003 DOI: 10.1016/j.cllc.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
493 Lucas JT, Kuremsky JG, Soike M, Hinson WW, Kearns WT, Hampton CJ, Blackstock AW, Urbanic J. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC). Lung Cancer 2014;85:59-65. [DOI: 10.1016/j.lungcan.2014.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
494 Sloth Møller D, Knap MM, Nyeng TB, Khalil AA, Holt MI, Kandi M, Hoffmann L. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer. Acta Oncol 2017;56:1604-9. [PMID: 28885090 DOI: 10.1080/0284186X.2017.1373848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
495 Nantavithya C, Saksornchai K, Oonsiri P, Shotelersuk K. Dosimetric study of three-dimensional conformal radiotherapy, electronic compensator technique, intensity-modulated radiation therapy and volumetric-modulated arc therapy in whole breast irradiation. J Radiother Pract 2017;16:431-43. [DOI: 10.1017/s1460396917000243] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
496 Wu ZF, Zhang JY, Shen XY, Zhou LY, Gao YB, Hu Y, Zeng ZC. A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma. Med Phys 2016;43:4349. [PMID: 27370150 DOI: 10.1118/1.4953831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
497 Cazoulat G, Balter JM, Matuszak MM, Jolly S, Owen D, Brock KK. Mapping lung ventilation through stress maps derived from biomechanical models of the lung. Med Phys 2021;48:715-23. [PMID: 33617034 DOI: 10.1002/mp.14643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
498 Cho Y, Cho YJ, Chang WS, Kim JW, Choi WH, Lee IJ. Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation. Radiat Oncol 2019;14:56. [PMID: 30935400 DOI: 10.1186/s13014-019-1257-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
499 Anker CJ, Grossmann KF, Atkins MB, Suneja G, Tarhini AA, Kirkwood JM. Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG). Int J Radiat Oncol Biol Phys 2016;95:632-46. [PMID: 27131079 DOI: 10.1016/j.ijrobp.2016.01.038] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
500 Kishan AU, Wang PC, Sheng K, Yu V, Ruan D, Cao M, Tenn S, Low DA, Lee P. Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy. Technol Cancer Res Treat 2015;14:411-8. [PMID: 25261069 DOI: 10.1177/1533034614551476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
501 Hinton T, Karnak D, Tang M, Jiang R, Luo Y, Boonstra P, Sun Y, Nancarrow DJ, Sandford E, Ray P, Maurino C, Matuszak M, Schipper MJ, Green MD, Yanik GA, Tewari M, Naqa IE, Schonewolf CA, Haken RT, Jolly S, Lawrence TS, Ray D. Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis. Transl Oncol 2022;21:101428. [PMID: 35460942 DOI: 10.1016/j.tranon.2022.101428] [Reference Citation Analysis]
502 Hawkins PG, Boonstra PS, Hobson ST, Hearn JWD, Hayman JA, Ten Haken RK, Matuszak MM, Stanton P, Kalemkerian GP, Ramnath N, Lawrence TS, Schipper MJ, Spring Kong FM, Jolly S. Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship. Radiother Oncol 2017;125:66-72. [PMID: 28947099 DOI: 10.1016/j.radonc.2017.09.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
503 Jarzebska N, Karetnikova ES, Markov AG, Kasper M, Rodionov RN, Spieth PM. Scarred Lung. An Update on Radiation-Induced Pulmonary Fibrosis. Front Med (Lausanne) 2020;7:585756. [PMID: 33521012 DOI: 10.3389/fmed.2020.585756] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
504 Guo JH, Chen MQ, Chen C, Lu HJ, Xu BH. Efficacy and toxicity of nimotuzumab combined with radiotherapy in elderly patients with esophageal squamous cell carcinoma. Mol Clin Oncol 2015;3:1135-8. [PMID: 26623065 DOI: 10.3892/mco.2015.606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
505 Blais E, Vendrely V, Sargos P, Créhange G, Huguet F, Maingon P, Simon JM, Bourdais R, Ozsahin M, Bourhis J, Clément-Colmou K, Belghith B, Proudhom Briois MA, Gilliot O, Dujols JP, Peyras A, Dupin C, Riet FG, Canova CH, Huertas A, Troussier I. [Chemoradiation for oesophageal cancer: A critical review of the literature]. Cancer Radiother 2019;23:62-72. [PMID: 30639379 DOI: 10.1016/j.canrad.2018.05.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
506 Latifi K, Forster KM, Hoffe SE, Dilling TJ, van Elmpt W, Dekker A, Zhang GG. Dependence of ventilation image derived from 4D CT on deformable image registration and ventilation algorithms. J Appl Clin Med Phys 2013;14:4247. [PMID: 23835389 DOI: 10.1120/jacmp.v14i4.4247] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
507 Effeney B, Biggs J, Brady C, Pemberton M, Sim L, Pullar A. Considerations and adaptions to the modulated arc total body irradiation technique: dosimetry description. J Med Radiat Sci 2019;66:284-91. [PMID: 31696648 DOI: 10.1002/jmrs.363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
508 Mendes F, Antunes C, Abrantes AM, Gonçalves AC, Nobre-gois I, Sarmento AB, Botelho MF, Rosa MS. Lung cancer: the immune system and radiation. British Journal of Biomedical Science 2016;72:78-84. [DOI: 10.1080/09674845.2015.11666801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
509 Zhu J, Chen G, Niu K, Feng Y, Xie L, Qin S, Wang Z, Li J, Lang S, Zhuo W, Chen Z, Sun J. Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer. Future Oncol 2022. [PMID: 34986655 DOI: 10.2217/fon-2021-1239] [Reference Citation Analysis]
510 Balaji K, Balaji Subramanian S, Sathiya K, Thirunavukarasu M, Anu Radha C, Ramasubramanian V. Hybrid planning techniques for hypofractionated whole-breast irradiation using flattening filter-free beams. Strahlenther Onkol 2020;196:376-85. [PMID: 31863154 DOI: 10.1007/s00066-019-01555-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
511 Schröder C, Buchali A, Windisch P, Vu E, Basler L, Zwahlen DR, Förster R. Impact of Low-Dose Irradiation of the Lung and Heart on Toxicity and Pulmonary Function Parameters after Thoracic Radiotherapy. Cancers (Basel) 2020;13:E22. [PMID: 33374564 DOI: 10.3390/cancers13010022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 Rankine LJ, Wang Z, Driehuys B, Marks LB, Kelsey CR, Das SK. Correlation of Regional Lung Ventilation and Gas Transfer to Red Blood Cells: Implications for Functional-Avoidance Radiation Therapy Planning. Int J Radiat Oncol Biol Phys 2018;101:1113-22. [PMID: 29907488 DOI: 10.1016/j.ijrobp.2018.04.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
513 Blais E, Pichon B, Mampuya A, Antoine M, Lagarde P, Kantor G, Breton-callu C, Lefebvre C, Gerard M, Aamarcha A, Ozsahin M, Bourhis J, Maingon P, Troussier I, Pourel N. Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie stéréotaxique : les poumons. Cancer/Radiothérapie 2017;21:584-96. [DOI: 10.1016/j.canrad.2017.07.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
514 Ko YE, Ahn SD, Je HU. Usability and necessity of a novel hybrid radiation therapy technique based on volumetric modulated arc therapy (VMAT) in stage III lung cancer treatment. Radiation Physics and Chemistry 2022. [DOI: 10.1016/j.radphyschem.2022.110054] [Reference Citation Analysis]
515 Pollock S, Lee D, Keall P, Kim T. Audiovisual biofeedback improves motion prediction accuracy. Med Phys 2013;40:041705. [PMID: 23556875 DOI: 10.1118/1.4794497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
516 Liang B, Tian Y, Chen X, Yan H, Yan L, Zhang T, Zhou Z, Wang L, Dai J. Prediction of Radiation Pneumonitis With Dose Distribution: A Convolutional Neural Network (CNN) Based Model. Front Oncol 2019;9:1500. [PMID: 32076596 DOI: 10.3389/fonc.2019.01500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
517 Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose. Int J Radiat Oncol Biol Phys 2013;85:522-7. [PMID: 22580121 DOI: 10.1016/j.ijrobp.2012.03.052] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
518 St-Hilaire J, Lavoie C, Dagnault A, Beaulieu F, Morin F, Beaulieu L, Tremblay D. Functional avoidance of lung in plan optimization with an aperture-based inverse planning system. Radiother Oncol 2011;100:390-5. [PMID: 21963286 DOI: 10.1016/j.radonc.2011.09.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
519 Vinogradskiy Y, Castillo R, Castillo E, Schubert L, Jones BL, Faught A, Gaspar LE, Kwak J, Bowles DW, Waxweiler T, Dougherty JM, Gao D, Stevens C, Miften M, Kavanagh B, Grills I, Rusthoven CG, Guerrero T. Results of a multi-institutional phase II clinical trial for 4DCT-ventilation functional avoidance thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)03070-4. [PMID: 34767934 DOI: 10.1016/j.ijrobp.2021.10.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
520 Chen L, Zhao Y, Xu F. [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2014;17:351-6. [PMID: 24758912 DOI: 10.3779/j.issn.1009-3419.2014.04.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
521 Krasin MJ, Constine LS, Friedman DL, Marks LB. Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other. Semin Radiat Oncol 2010;20:21-9. [PMID: 19959028 DOI: 10.1016/j.semradonc.2009.09.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
522 Hussain S, Dutta A, Sarkar A, Singh A, Gupta ML, Biswas S. Proteomic analysis of irradiated lung tissue of mice using gel-based proteomic approach. Int J Radiat Biol 2017;93:373-80. [PMID: 28000521 DOI: 10.1080/09553002.2016.1266058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
523 Hoffmann AL, Troost EG, Huizenga H, Kaanders JH, Bussink J. Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial. Int J Radiat Oncol Biol Phys 2012;83:1596-602. [PMID: 22245206 DOI: 10.1016/j.ijrobp.2011.10.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
524 Sathiyaraj P, Manikandan P, Varatharaj C, Ganesh K, Sathiyan S, Ravikumar M. Dosimetric evaluation of hybrid and volumetric-modulated arc therapy plan for left-sided chest wall irradiation in MONACO treatment planning system. J Can Res Ther 2022;0:0. [DOI: 10.4103/jcrt.jcrt_707_20] [Reference Citation Analysis]
525 Fleckenstein J, Boda-Heggemann J, Siebenlist K, Gudzheva T, Prakofyeva N, Lohr F, Wenz F, Simeonova-Chergou A. Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT. Strahlenther Onkol 2018;194:815-23. [PMID: 29802434 DOI: 10.1007/s00066-018-1316-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
526 Tatsuno S, Doi H, Okada W, Inoue E, Nakamatsu K, Tanooka M, Tanaka M, Nishimura Y. Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer. Sci Rep 2022;12:590. [PMID: 35022506 DOI: 10.1038/s41598-021-04601-0] [Reference Citation Analysis]
527 Takemoto S, Shibamoto Y, Hashizume C, Miyakawa A, Murai T, Yanagi T, Sugie C, Nagai A. Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer. J Radiat Res 2021;62:338-45. [PMID: 33480428 DOI: 10.1093/jrr/rraa131] [Reference Citation Analysis]
528 Amin NP, Miften M, Kavanagh B, Raben D, Camidge DR, Thornton D, Rochford N, Gaspar LE. Impact of Induction Chemotherapy on Estimated Risk of Radiation Pneumonitis in Small Cell Lung Cancer. Journal of Thoracic Oncology 2011;6:1553-62. [DOI: 10.1097/jto.0b013e318220c9f6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
529 Yamamoto T, Kabus S, Lorenz C, Mittra E, Hong JC, Chung M, Eclov N, To J, Diehn M, Loo BW Jr, Keall PJ. Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images. Int J Radiat Oncol Biol Phys 2014;90:414-22. [PMID: 25104070 DOI: 10.1016/j.ijrobp.2014.06.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
530 van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, van Dijk LV, van Dijk-Peters FB, Marteijn LA, de Bock GH, Burgerhof JG, Gietema JA, Langendijk JA, Maduro JH, Crijns AP. Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures. J Clin Oncol 2017;35:1171-8. [PMID: 28095159 DOI: 10.1200/JCO.2016.69.8480] [Cited by in Crossref: 157] [Cited by in F6Publishing: 77] [Article Influence: 31.4] [Reference Citation Analysis]
531 Shaverdian N, Beattie J, Thor M, Offin M, Shepherd AF, Gelblum DY, Wu AJ, Simone CB 2nd, Hellmann MD, Chaft JE, Rimner A, Gomez DR. Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors. Ann Oncol 2020;31:1719-24. [PMID: 33010460 DOI: 10.1016/j.annonc.2020.09.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
532 Munck af Rosenschöld P, Aznar MC, Nygaard DE, Persson GF, Korreman SS, Engelholm SA, Nyström H. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer. Acta Oncol 2010;49:1141-8. [PMID: 20831506 DOI: 10.3109/0284186X.2010.500620] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
533 Puttanawarut C, Sirirutbunkajorn N, Khachonkham S, Pattaranutaporn P, Wongsawat Y. Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients. Radiat Oncol 2021;16:220. [PMID: 34775975 DOI: 10.1186/s13014-021-01950-y] [Reference Citation Analysis]
534 Teo PT, Crow R, Van Nest S, Sasaki D, Pistorius S. Tracking lung tumour motion using a dynamically weighted optical flow algorithm and electronic portal imaging device. Meas Sci Technol 2013;24:074012. [DOI: 10.1088/0957-0233/24/7/074012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
535 Lutz CM, Knap MM, Hoffmann L, Møller DS, Hansen O, Brink C, Schytte T, Nyhus CH, McCulloch T, Borissova S, Alber M, Khalil AA. Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial. Clin Transl Radiat Oncol 2021;27:8-14. [PMID: 33385069 DOI: 10.1016/j.ctro.2020.11.013] [Reference Citation Analysis]
536 Onal C, Efe E, Guler OC, Yildirim BA. Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery. In Vivo 2019;33:2181-9. [PMID: 31662554 DOI: 10.21873/invivo.11720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
537 Hau E, Rains M, Pham T, Muirhead R, Yeghiaian Alvandi R. Potential benefits and pitfalls of respiratory-gated radiotherapy in the treatment of thoracic malignancy. Asia Pac J Clin Oncol 2014;10:e13-20. [PMID: 23298326 DOI: 10.1111/ajco.12053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
538 Hasse K, Neylon J, Min Y, O'Connell D, Lee P, Low DA, Santhanam AP. Feasibility of deriving a novel imaging biomarker based on patient-specific lung elasticity for characterizing the degree of COPD in lung SBRT patients. Br J Radiol 2019;92:20180296. [PMID: 30281329 DOI: 10.1259/bjr.20180296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
539 Glide-Hurst CK, Chetty IJ. Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies. J Thorac Dis 2014;6:303-18. [PMID: 24688775 DOI: 10.3978/j.issn.2072-1439.2013.11.10] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
540 Hsu AA, Tan EH, Takano AM. Lower Respiratory Tract Adenoid Cystic Carcinoma: Its Management in the Past Decades. Clin Oncol (R Coll Radiol) 2015;27:732-40. [PMID: 26160258 DOI: 10.1016/j.clon.2015.06.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
541 Balaji K, Yadav P, BalajiSubramanian S, Anu Radha C, Ramasubramanian V. Hybrid volumetric modulated arc therapy for chest wall irradiation: For a good plan, get the right mixture. Phys Med 2018;52:86-92. [PMID: 30139614 DOI: 10.1016/j.ejmp.2018.06.641] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
542 Liang X, Yu H, Yu R, Xu G, Zhu G. Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy. Mol Clin Oncol 2015;3:1172-6. [PMID: 26623072 DOI: 10.3892/mco.2015.588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
543 Chen KW, Hsu HT, Lin JF, Yeh HL, Yeh DC, Lin CY, Chan S, Hsieh HY. Adjuvant whole breast radiotherapy with simultaneous integrated boost to tumor bed with intensity modulated radiotherapy technique in elderly breast cancer patients. Transl Cancer Res 2020;9:S12-22. [PMID: 35117944 DOI: 10.21037/tcr.2019.07.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
544 Krafft SP, Rao A, Stingo F, Briere TM, Court LE, Liao Z, Martel MK. The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis. Med Phys 2018;45:5317-24. [PMID: 30133809 DOI: 10.1002/mp.13150] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
545 Borm KJ, Simonetto C, Kundrát P, Eidemüller M, Oechsner M, Düsberg M, Combs SE. Toxicity of internal mammary irradiation in breast cancer. Are concerns still justified in times of modern treatment techniques? Acta Oncol 2020;59:1201-9. [PMID: 32619381 DOI: 10.1080/0284186X.2020.1787509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
546 Türkkan G, Willems Y, Hendriks LEL, Mostard R, Conemans L, Gietema HA, Mitea C, Peeters S, De Ruysscher D. Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology. Radiother Oncol 2021;155:269-77. [PMID: 33245945 DOI: 10.1016/j.radonc.2020.11.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
547 Hansen O, Schytte T, Nielsen M, Brink C. Age dependent prognosis in concurrent chemo-radiation of locally advanced NSCLC. Acta Oncol 2015;54:333-9. [PMID: 25291077 DOI: 10.3109/0284186X.2014.958529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
548 Liem X, Chira C, Fourquet A, Campana F, Peurien D, Fournier-bidoz N, Kirova Y. Résultats préliminaires d’une tomothérapie hélicoïdale adjuvante avec boost intégré dans le cadre d’un traitement conservateur d’un cancer du sein. Cancer/Radiothérapie 2014;18:15-22. [DOI: 10.1016/j.canrad.2013.07.149] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
549 Jairam V, Pasha S, Soulos PR, Gross CP, Yu JB, Park HS, Decker RH. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques. Lung Cancer 2021;161:171-9. [PMID: 34607209 DOI: 10.1016/j.lungcan.2021.09.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
550 Lu YF, Lin YC, Chen KH, Shueng PW, Yeh HP, Hsieh CH. Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls. Onco Targets Ther 2016;9:3025-30. [PMID: 27284253 DOI: 10.2147/OTT.S102895] [Reference Citation Analysis]
551 Shi L, Lai Y, Chen S, Fu L, Lin Q. Dosimetric superiority of IMRT with jaw tracking technique for whole esophagus and T-shaped field radiotherapy in advanced esophageal cancer. PLoS One 2018;13:e0202628. [PMID: 30183753 DOI: 10.1371/journal.pone.0202628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
552 Xu H, Lee SW, Guerrero M, Yi BY, Chen S, Becker SJ, Chung H, Cheston SB. Dosimetric effects of the kV based image-guided radiation therapy of prone breast external beam radiation: Towards the optimized imaging frequency. J Appl Clin Med Phys 2019;20:212-9. [PMID: 30550644 DOI: 10.1002/acm2.12511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
553 Pandeli C, Smyth LML, David S, See AW. Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study. Radiat Oncol 2019;14:223. [PMID: 31822293 DOI: 10.1186/s13014-019-1430-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
554 Vinod S, Choong C, Vial P, Kron T, Ball D. Lung organ-at-risk volumes: A survey of practice and the need for a consistent definition in the 4DCT era. J Med Imaging Radiat Oncol 2020;64:120-6. [PMID: 31755648 DOI: 10.1111/1754-9485.12972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
555 Tong AN, Yan P, Yuan GH, Lv XY, Gong H, Zhao H, Wang YM. Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy. Mol Clin Oncol 2015;3:442-8. [PMID: 25798283 DOI: 10.3892/mco.2014.475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
556 Ohno T, Oshiro Y, Mizumoto M, Numajiri H, Ishikawa H, Okumura T, Terunuma T, Sakae T, Sakurai H. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer. J Radiat Res 2015;56:128-33. [PMID: 25368341 DOI: 10.1093/jrr/rru082] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
557 Antonic V, Rabbani ZN, Jackson IL, Vujaskovic Z. Subcutaneous administration of bovine superoxide dismutase protects lungs from radiation-induced lung injury. Free Radic Res 2015;49:1259-68. [PMID: 26110460 DOI: 10.3109/10715762.2015.1066501] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
558 Kolacio MŠ, Rajlić D, Radojčić M, Radojčić ĐS, Obajdin N, Debeljuh DD, Jurković S. Dosimetric accuracy of three dose calculation algorithms for radiation therapy of in situ non-small cell lung carcinoma. Rep Pract Oncol Radiother 2022;27:86-96. [PMID: 35402037 DOI: 10.5603/RPOR.a2022.0013] [Reference Citation Analysis]
559 Ohta A, Kaidu M, Tanabe S, Utsunomiya S, Sasamoto R, Maruyama K, Tanaka K, Saito H, Nakano T, Shioi M, Takahashi H, Kushima N, Abe E, Aoyama H. Respiratory gating and multifield technique radiotherapy for esophageal cancer. Jpn J Radiol 2017;35:95-100. [DOI: 10.1007/s11604-016-0606-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
560 Kim T, Kim S, Park Y, Youn KK, Keall P, Lee R. Motion management within two respiratory-gating windows: feasibility study of dual quasi-breath-hold technique in gated medical procedures. Phys Med Biol 2014;59:6583-94. [DOI: 10.1088/0031-9155/59/21/6583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
561 Shi Z, Foley KG, Pablo de Mey J, Spezi E, Whybra P, Crosby T, van Soest J, Dekker A, Wee L. External Validation of Radiation-Induced Dyspnea Models on Esophageal Cancer Radiotherapy Patients. Front Oncol 2019;9:1411. [PMID: 31921668 DOI: 10.3389/fonc.2019.01411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
562 Wang L, Gao Z, Li C, Sun L, Li J, Yu J, Meng X. Computed Tomography-Based Delta-Radiomics Analysis for Discriminating Radiation Pneumonitis in Patients With Esophageal Cancer After Radiation Therapy. Int J Radiat Oncol Biol Phys 2021;111:443-55. [PMID: 33974887 DOI: 10.1016/j.ijrobp.2021.04.047] [Reference Citation Analysis]
563 Pollock S, O'Brien R, Makhija K, Hegi-Johnson F, Ludbrook J, Rezo A, Tse R, Eade T, Yeghiaian-Alvandi R, Gebski V, Keall PJ. Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial. BMC Cancer 2015;15:526. [PMID: 26187714 DOI: 10.1186/s12885-015-1483-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
564 Chen J, Hong J, Zou X, Lv W, Guo F, Hong H, Zhang W. Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis. J Radiat Res 2015;56:883-8. [PMID: 26454068 DOI: 10.1093/jrr/rrv057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
565 Briere TM, Agrusa JE, Martel MK, Jackson A, Olch AJ, Ronckers CM, Kremer LCM, Constine LS, McAleer MF. Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys 2022:S0360-3016(22)00132-8. [PMID: 35525723 DOI: 10.1016/j.ijrobp.2022.01.052] [Reference Citation Analysis]
566 Blakaj DM, Zhang HG, Blakaj A, Mourad WF, Clarke B, Spierer M, Kalnicki S, Guha C. Clinical and molecular exploration of the impact of radiation therapy on Marfan syndrome patients. Pract Radiat Oncol 2013;3:e127-30. [PMID: 24674374 DOI: 10.1016/j.prro.2012.07.006] [Reference Citation Analysis]
567 Oberije C, Nalbantov G, Dekker A, Boersma L, Borger J, Reymen B, van Baardwijk A, Wanders R, De Ruysscher D, Steyerberg E, Dingemans AM, Lambin P. A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making. Radiother Oncol 2014;112:37-43. [PMID: 24846083 DOI: 10.1016/j.radonc.2014.04.012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
568 Vogelius IS, Westerly DC, Cannon GM, Bentzen SM. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol 2010;49:1052-7. [PMID: 20831495 DOI: 10.3109/0284186X.2010.498835] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
569 Paganetti H, Beltran C, Both S, Dong L, Flanz J, Furutani K, Grassberger C, Grosshans DR, Knopf A, Langendijk JA, Nystrom H, Parodi K, Raaymakers BW, Richter C, Sawakuchi GO, Schippers M, Shaitelman SF, Teo BKK, Unkelbach J, Wohlfahrt P, Lomax T. Roadmap: proton therapy physics and biology. Phys Med Biol 2021;66:05RM01. [DOI: 10.1088/1361-6560/abcd16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
570 Li N, Luo P, Li C, Hong Y, Zhang M, Chen Z. Analysis of related factors of radiation pneumonia caused by precise radiotherapy of esophageal cancer based on random forest algorithm. Math Biosci Eng 2021;18:4477-90. [PMID: 34198449 DOI: 10.3934/mbe.2021227] [Reference Citation Analysis]
571 Milano MT, Mihai A, Kang J, Singh DP, Verma V, Qiu H, Chen Y, Kong F(. Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints. Expert Review of Anticancer Therapy 2019;19:959-69. [DOI: 10.1080/14737140.2019.1686980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
572 Inoue H, Ono A, Kawabata T, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Kenmotsu H, Naito T, Murakami H, Yasui K, Ogawa H, Onoe T, Endo M, Harada H, Takahashi T. Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer. Invest New Drugs 2020;38:1612-7. [PMID: 32128667 DOI: 10.1007/s10637-020-00917-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
573 Zhang X, Hadley C, Jackson IL, Zhang Y, Zhang A, Spasojevic I, Haberle IB, Vujaskovic Z. Hypo-CpG methylation controls PTEN expression and cell apoptosis in irradiated lung. Free Radic Res 2016;50:875-86. [PMID: 27367846 DOI: 10.1080/10715762.2016.1189078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
574 Lin G, Xiao H, Zeng Z, Xu Z, He J, Sun T, Liu J, Guo G, Ji W, Hu Y. Constraints for symptomatic radiation pneumonitis of helical tomotherapy hypofractionated simultaneous multitarget radiotherapy for pulmonary metastasis from hepatocellular carcinoma. Radiother Oncol. 2017;123:246-250. [PMID: 28314468 DOI: 10.1016/j.radonc.2017.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
575 Tucker SL, Liu A, Gomez D, Tang LL, Allen P, Yang J, Liao Z, Grosshans D. Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation. Radiotherapy and Oncology 2016;119:495-500. [DOI: 10.1016/j.radonc.2016.04.025] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
576 Roy S, Salerno KE, Citrin DE. Biology of Radiation-Induced Lung Injury. Semin Radiat Oncol 2021;31:155-61. [PMID: 33610273 DOI: 10.1016/j.semradonc.2020.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Lei W, Jia J, Cao R, Song J, Hu L. Impacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer. J Appl Clin Med Phys 2017;18:22-8. [PMID: 28656685 DOI: 10.1002/acm2.12104] [Reference Citation Analysis]
578 Tseng YD, Cutter DJ, Plastaras JP, Parikh RR, Cahlon O, Chuong MD, Dedeckova K, Khan MK, Lin SY, McGee LA, Shen EY, Terezakis SA, Badiyan SN, Kirova YM, Hoppe RT, Mendenhall NP, Pankuch M, Flampouri S, Ricardi U, Hoppe BS. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee. Int J Radiat Oncol Biol Phys 2017;99:825-42. [PMID: 28943076 DOI: 10.1016/j.ijrobp.2017.05.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
579 Hepel JT, Peter J, Hiatt JR, Patel S, Osibanjo O, Safran H, Curran B, Dipetrillo T. Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer. Front Oncol 2012;2:124. [PMID: 23057009 DOI: 10.3389/fonc.2012.00124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
580 Bai H, Li W, Xia Y, Li L, Gao J, Liu X. Preliminary Study on the Effect of 4DCT-Ventilation-Weighted Dose on the Radiation Induced Pneumonia Probability (RIPP). Dose Response 2021;19:15593258211017753. [PMID: 34377108 DOI: 10.1177/15593258211017753] [Reference Citation Analysis]
581 Meng Y, Yang H, Wang W, Tang X, Jiang C, Shen Y, Luo W. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients. Radiat Oncol 2019;14:7. [PMID: 30642354 DOI: 10.1186/s13014-018-1204-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
582 Oertel M, Kittel C, Martel J, Mikesch JH, Glashoerster M, Stelljes M, Eich HT. Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data. Cancers (Basel) 2021;13:2946. [PMID: 34204603 DOI: 10.3390/cancers13122946] [Reference Citation Analysis]
583 Boman E, Rossi M, Kapanen M. The robustness of dual isocenter VMAT radiation therapy for bilateral lymph node positive breast cancer. Physica Medica 2017;44:11-7. [DOI: 10.1016/j.ejmp.2017.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
584 Scotti V, Saieva C, Di Cataldo V, Bruni A, Desideri I, Bertocci S, Meattini I, Livi L, Simontacchi G, De Luca Cardillo C, Bendinelli B, Bastiani P, Mangoni M, Agresti B, Biti G. Vinorelbine-Based Chemo-Radiotherapy in Non-Small Cell Lung Cancer. Tumori 2012;98:464-70. [DOI: 10.1177/030089161209800411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
585 Lee J, Kim SW, Son SH. Dosimetric evaluation of incidental irradiation to the axilla during whole breast radiotherapy for patients with left-sided early breast cancer in the IMRT era. Medicine (Baltimore) 2016;95:e4036. [PMID: 27368030 DOI: 10.1097/MD.0000000000004036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
586 Zawadzka A, Nesteruk M, Brzozowska B, Kukołowicz PF. Method of predicting the mean lung dose based on a patient׳s anatomy and dose-volume histograms. Med Dosim 2017;42:57-62. [PMID: 28237293 DOI: 10.1016/j.meddos.2016.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
587 Mukesh M, Harris E, Jena R, Evans P, Coles C. Relationship between irradiated breast volume and late normal tissue complications: a systematic review. Radiother Oncol 2012;104:1-10. [PMID: 22682540 DOI: 10.1016/j.radonc.2012.04.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
588 Valakh V, Brandfass J. Relative Safety of External Beam Radiation Therapy in Lung Transplant Recipients Who Develop Thoracic Malignancies. Transplantation Proceedings 2015;47:2743-5. [DOI: 10.1016/j.transproceed.2015.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
589 Zaric B, Stojsic V, Tepavac A, Sarcev T, Zarogoulidis P, Darwiche K, Tsakiridis K, Karapantzos I, Kesisis G, Kougioumtzi I, Katsikogiannis N, Machairiotis N, Stylianaki A, Foroulis CN, Zarogoulidis K, Perin B. Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC). J Thorac Dis 2013;5 Suppl 4:S371-7. [PMID: 24102009 DOI: 10.3978/j.issn.2072-1439.2013.05.16] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
590 Meng Y, Luo W, Wang W, Zhou C, Zhou S, Tang X, Hou L, Kong FS, Yang H. Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy. Front Oncol 2020;10:584756. [PMID: 33178612 DOI: 10.3389/fonc.2020.584756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
591 Xu L, Jiang J, Li Y, Zhang L, Li Z, Xian J, Jiang C, Diao Y, Su X, Xu H, Zhang Y, Zhang T, Yang Z, Tan B, Li H. Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy. Cancer Med 2019;8:2599-611. [PMID: 30897289 DOI: 10.1002/cam4.2088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
592 Stervik L, Pettersson N, Scherman J, Behrens CF, Ceberg C, Engelholm S, Gunnarsson K, Hallqvist A, Nyman J, Persson GF, Pøhl M, Wahlstedt I, Vogelius IR, Bäck A. Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studies. Acta Oncol 2020;59:628-35. [PMID: 32202189 DOI: 10.1080/0284186X.2020.1739331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
593 de Haan R, van Werkhoven E, van den Heuvel MM, Peulen HMU, Sonke GS, Elkhuizen P, van den Brekel MWM, Tesselaar MET, Vens C, Schellens JHM, van Triest B, Verheij M. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib. BMC Cancer 2019;19:901. [PMID: 31500595 DOI: 10.1186/s12885-019-6121-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
594 Imano N, Kimura T, Kawahara D, Nishioka R, Fukumoto W, Kawano R, Kubo K, Katsuta T, Takeuchi Y, Nishibuchi I, Murakami Y, Horimasu Y, Masuda T, Fujitaka K, Hattori N, Nagata Y. Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients. Jpn J Clin Oncol 2021:hyab163. [PMID: 34625805 DOI: 10.1093/jjco/hyab163] [Reference Citation Analysis]
595 Jan N, Guy C, Reshko LB, Hugo GD, Weiss E. Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2017;98:683-90. [PMID: 28581410 DOI: 10.1016/j.ijrobp.2017.02.227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
596 Kelsey CR, Christensen JD, Chino JP, Adamson J, Ready NE, Perez BA. Adaptive planning using positron emission tomography for locally advanced lung cancer: A feasibility study. Practical Radiation Oncology 2016;6:96-104. [DOI: 10.1016/j.prro.2015.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
597 Peterlin P, Stanič K, Méndez I, Strojnik A. Treating lung cancer with dynamic conformal arc therapy: a dosimetric study. Radiat Oncol 2017;12:93. [PMID: 28578699 DOI: 10.1186/s13014-017-0823-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
598 Finazzi T, Nguyen VT, Zimmermann F, Papachristofilou A. Impact of patient and treatment characteristics on heart and lung dose in adjuvant radiotherapy for left-sided breast cancer. Radiat Oncol 2019;14:153. [PMID: 31462267 DOI: 10.1186/s13014-019-1364-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
599 van Baardwijk A, Reymen B, Wanders S, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R. Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer. Eur J Cancer. 2012;48:2339-2346. [PMID: 22608261 DOI: 10.1016/j.ejca.2012.04.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
600 Sekine I, Sumi M, Ito Y, Horinouchi H, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Kubota K, Tamura T. Phase I Study of Concurrent High-Dose Three-Dimensional Conformal Radiotherapy With Chemotherapy Using Cisplatin and Vinorelbine for Unresectable Stage III Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 2012;82:953-9. [DOI: 10.1016/j.ijrobp.2011.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
601 Desai D, Narayanasamy G, Bimali M, Cordrey I, Elasmar H, Srinivasan S, Johnson EL. Cleaning the dose falloff in lung SBRT plan. J Appl Clin Med Phys 2021;22:100-8. [PMID: 33285036 DOI: 10.1002/acm2.13113] [Reference Citation Analysis]
602 Kawakami W, Takamatsu S, Taka M, Ishii K, Nakaichi T, Funamoto K, Yokoyama K. Factors Associated With Radiation Pneumonitis in Patients Receiving Electron Boost Radiation for Breast-Conserving Therapy: A Retrospective Review. Adv Radiat Oncol 2020;5:1141-6. [PMID: 33305074 DOI: 10.1016/j.adro.2020.08.009] [Reference Citation Analysis]
603 Amin NP, Miften M, Thornton D, Ryan N, Kavanagh B, Gaspar LE. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer. Med Dosim 2013;38:320-6. [PMID: 23611631 DOI: 10.1016/j.meddos.2013.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
604 Wang J, Jin X, Zhao K, Peng J, Xie J, Chen J, Zhang Z, Studenski M, Hu W. Patient feature based dosimetric Pareto front prediction in esophageal cancer radiotherapy. Med Phys 2015;42:1005-11. [PMID: 25652513 DOI: 10.1118/1.4906252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
605 Fakhrian K, Oechsner M, Kampfer S, Schuster T, Molls M, Geinitz H. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma. Strahlenther Onkol 2013;189:293-300. [PMID: 23443611 DOI: 10.1007/s00066-012-0297-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
606 Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, Brink C. Influence of dose calculation algorithms on the predicted dose distribution and NTCP values for NSCLC patients. Med Phys. 2011;38:2412-2418. [PMID: 21776775 DOI: 10.1118/1.3575418] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
607 Lancellotta V, Chierchini S, Perrucci E, Saldi S, Falcinelli L, Iacco M, Zucchetti C, Palumbo I, Bini V, Aristei C. Skin toxicity after chest wall/breast plus level III-IV lymph nodes treatment with helical tomotherapy. Cancer Invest 2018;36:504-11. [PMID: 30516084 DOI: 10.1080/07357907.2018.1545854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
608 Takahashi S, Go T, Kasai Y, Yokomise H, Shibata T. Relationship between dose-volume parameters and pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for lung cancer. Strahlenther Onkol 2016;192:658-67. [PMID: 27418130 DOI: 10.1007/s00066-016-1021-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
609 Deng Y, Qiu T, Patel N, Zhou S, Xue T, Zhang H. Clinical Management of Risk of Radiation Pneumonia with Serum Markers During the Radiotherapy for Patients with Thoracic Malignant Tumors. Cancer Manag Res 2019;11:10249-56. [PMID: 31824195 DOI: 10.2147/CMAR.S231995] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
610 Blitzblau RC, Horton JK. Treatment planning technique in patients receiving postmastectomy radiation therapy. Practical Radiation Oncology 2013;3:241-8. [DOI: 10.1016/j.prro.2012.09.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
611 Rodríguez De Dios N, Navarro-Martin A, Cigarral C, Chicas-Sett R, García R, Garcia V, Gonzalez JA, Gonzalo S, Murcia-Mejía M, Robaina R, Sotoca A, Vallejo C, Valtueña G, Couñago F. GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer. World J Clin Oncol 2022; 13(4): 237-266 [DOI: 10.5306/wjco.v13.i4.237] [Reference Citation Analysis]